%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Barbara Rossetti, Roberta Gagliardini, Genny Meini, Gaetana Sterrantino, Vincenzo Colangeli, Maria Carla Re, Alessandra Latini, Manuela Colafigli, Francesca Vignale, Stefano Rusconi, Valeria Micheli, Antonio Di Biagio, Giancarlo Orofino, Valeria Ghisetti, Alessandra Fantauzzi, Vincenzo Vullo, Pierfrancesco Grima, Daniela Francisci, Claudio Mastroianni, Andrea Antinori, Michele Trezzi, Lucia Lisi, Pierluigi Navarra, Benedetta Canovari, Antonella D’Arminio Monforte, Silvia Lamonica, Alessandro D’Avino, Maurizio Zazzi, Simona Di Giambenedetto, Andrea De Luca, for GUSTA trial study group
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref002)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref004)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref007)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref008)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref009)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref012)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref013)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref014)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref016)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref017)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref018)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref019)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref020)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref021)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref018)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref022)>>
endobj
32 0 obj
<>/Border[0 0 0]/A 33 0 R>>
endobj
33 0 obj
<>
endobj
13 0 obj
[34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R]
endobj
34 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 511.4546 m
199.9998 511.4546 l
199.9998 511.9546 l
575.9997 511.9546 l
f*
0.83 0.64 0.02 0 k
300.3591 406.9417 m
305.1213 406.9417 l
h
f*
497.537 380.9197 m
502.2425 380.9197 l
h
f*
507.4583 380.9197 m
512.2205 380.9197 l
h
f*
297.1843 354.8976 m
301.9465 354.8976 l
h
f*
307.1622 354.8976 m
311.9244 354.8976 l
h
f*
528.7748 354.8976 m
533.537 354.8976 l
h
f*
354.5575 328.9323 m
359.3197 328.9323 l
h
f*
364.4787 328.9323 m
374.0031 328.9323 l
h
f*
470.2677 315.9496 m
479.7921 315.9496 l
h
f*
219.685 289.9276 m
229.1528 289.9276 l
h
f*
234.3685 289.9276 m
243.8362 289.9276 l
h
f*
547.2 276.9449 m
556.7244 276.9449 l
h
f*
371.6787 250.9228 m
381.2031 250.9228 l
h
f*
227.0551 185.8961 m
236.5795 185.8961 l
h
f*
455.4142 185.8961 m
464.8819 185.8961 l
h
f*
470.0976 185.8961 m
479.5654 185.8961 l
h
f*
203.4142 172.9134 m
212.9386 172.9134 l
h
f*
485.8016 81.9213 m
495.326 81.9213 l
h
f*
0 g
1 j
1 J
11.4998 0 0 11.4998 200.0125 706.3937 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Results)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 689.3858 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(In)Tj
1.0443 0 Td
(June)Tj
2.3632 0 Td
(2015,)Tj
2.6914 0 Td
(115)Tj
1.8679 0 Td
(patients)Tj
3.682 0 Td
(were)Tj
2.3632 0 Td
(evaluable)Tj
4.434 0 Td
(for)Tj
1.3785 0 Td
(the)Tj
1.5934 0 Td
(primary)Tj
3.5209 0 Td
(outcome)Tj
4.0162 0 Td
(\(56)Tj
1.6471 0 Td
(study,)Tj
2.8704 0 Td
(59)Tj
1.3129 0 Td
(continua-)Tj
-34.7854 -1.474 Td
(tion)Tj
1.8081 0 Td
(arm\).)Tj
2.5363 0 Td
(The)Tj
1.9276 0 Td
(study)Tj
2.5899 0 Td
(was)Tj
1.9813 0 Td
(discontinued)Tj
5.7588 0 Td
(due)Tj
1.8678 0 Td
(to)Tj
1.0444 0 Td
(excess)Tj
3.3061 0 Td
(of)Tj
1.0443 0 Td
(VF)Tj
1.4979 0 Td
(in)Tj
0.9787 0 Td
(the)Tj
1.5993 0 Td
(study)Tj
2.584 0 Td
(arm)Tj
1.9335 0 Td
(\(7)Tj
1.0981 0 Td
(cases,)Tj
-33.5561 -1.468 Td
(12.5%,)Tj
3.3001 0 Td
(vs)Tj
1.2174 0 Td
(0)Tj
0.7638 0 Td
(in)Tj
0.9847 0 Td
(the)Tj
1.5993 0 Td
(continuation)Tj
5.538 0 Td
(arm,)Tj
2.208 0 Td
(p)Tj
0.7699 0 Td
(=)Tj
0.7996 0 Td
(0.005\).)Tj
3.3001 0 Td
(The)Tj
1.9276 0 Td
(proportion)Tj
4.6607 0 Td
(free)Tj
1.9276 0 Td
(of)Tj
1.0443 0 Td
(treatment)Tj
4.4101 0 Td
(failure)Tj
2.9003 0 Td
(was)Tj
-37.3515 -1.474 Td
(73.2%)Tj
3.0256 0 Td
(in)Tj
0.9846 0 Td
(the)Tj
1.5934 0 Td
(study)Tj
2.5899 0 Td
(and)Tj
1.8619 0 Td
(59.3%)Tj
3.0257 0 Td
(in)Tj
0.9846 0 Td
(the)Tj
1.5993 0 Td
(continuation)Tj
5.538 0 Td
(arm.)Tj
2.2081 0 Td
(Two)Tj
2.0946 0 Td
(participants)Tj
5.2694 0 Td
(in)Tj
0.9847 0 Td
(the)Tj
1.5934 0 Td
(study)Tj
2.5899 0 Td
(and)Tj
1.8679 0 Td
(10)Tj
-37.811 -1.474 Td
(in)Tj
0.9846 0 Td
(the)Tj
1.5934 0 Td
(continuation)Tj
5.5439 0 Td
(arm)Tj
1.9276 0 Td
(discontinued)Tj
5.7588 0 Td
(therapy)Tj
3.5209 0 Td
(due)Tj
1.8679 0 Td
(to)Tj
1.0443 0 Td
(adverse)Tj
3.7358 0 Td
(events)Tj
3.1389 0 Td
(\(p)Tj
1.0981 0 Td
(=)Tj
0.7997 0 Td
(0.030\).)Tj
3.3001 0 Td
(At)Tj
1.1577 0 Td
(VF,)Tj
1.7724 0 Td
(no)Tj
-37.2441 -1.474 Td
(emergent)Tj
4.3981 0 Td
(drug)Tj
2.1961 0 Td
(resistance)Tj
4.7264 0 Td
(was)Tj
1.9813 0 Td
(detected.)Tj
4.2967 0 Td
(Co-receptor)Tj
5.4365 0 Td
(tropism)Tj
3.4672 0 Td
(switched)Tj
4.0699 0 Td
(to)Tj
1.0444 0 Td
(non-R5)Tj
3.4612 0 Td
(in)Tj
0.9847 0 Td
(one)Tj
-36.0625 -1.474 Td
(patient.)Tj
3.4612 0 Td
(Patients)Tj
3.7954 0 Td
(with)Tj
1.9753 0 Td
(VF)Tj
1.4979 0 Td
(reported)Tj
3.8969 0 Td
(lower)Tj
2.578 0 Td
(adherence)Tj
4.8875 0 Td
(and)Tj
1.8679 0 Td
(had)Tj
1.8679 0 Td
(lower)Tj
2.578 0 Td
(plasma)Tj
3.4075 0 Td
(drug)Tj
2.1961 0 Td
(levels.)Tj
3.0137 0 Td
(Fem-)Tj
-37.0233 -1.4741 Td
(oral)Tj
1.8619 0 Td
(bone)Tj
2.4109 0 Td
(mineral)Tj
3.4612 0 Td
(density)Tj
3.3479 0 Td
(was)Tj
1.9812 0 Td
(significantly)Tj
5.3172 0 Td
(improved)Tj
4.2908 0 Td
(in)Tj
0.9846 0 Td
(the)Tj
1.5934 0 Td
(study)Tj
2.584 0 Td
(arm.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 555.9307 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 538.9795 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Switching)Tj
4.4459 0 Td
(to)Tj
1.0503 0 Td
(maraviroc)Tj
4.5592 0 Td
(with)Tj
1.9813 0 Td
(darunavir/ritonavir)Tj
8.116 0 Td
(qd)Tj
1.3189 0 Td
(in)Tj
0.9846 0 Td
(virologically)Tj
5.3113 0 Td
(suppressed)Tj
5.3291 0 Td
(patients)Tj
3.682 0 Td
(was)Tj
-36.7786 -1.474 Td
(associated)Tj
4.9471 0 Td
(with)Tj
1.9753 0 Td
(improved)Tj
4.2848 0 Td
(tolerability)Tj
4.6548 0 Td
(but)Tj
1.5933 0 Td
(was)Tj
1.9813 0 Td
(virologically)Tj
5.3112 0 Td
(inferior)Tj
3.2345 0 Td
(to)Tj
1.0443 0 Td
(3-drug)Tj
3.0734 0 Td
(therapy.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 450.9921 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 433.9842 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Antiretroviral)Tj
5.7599 0 Td
(therapy)Tj
3.2485 0 Td
(\(ART\))Tj
2.8176 0 Td
(significantly)Tj
5.091 0 Td
(reduces)Tj
3.2768 0 Td
(morbidity)Tj
4.2406 0 Td
(and)Tj
1.7292 0 Td
(mortality)Tj
3.9174 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
-34.3386 -1.2982 Td
(HIV)Tj
2.0182 0 Td
(infection;)Tj
4.0195 0 Td
(this)Tj
1.6724 0 Td
(is)Tj
0.8504 0 Td
(best)Tj
1.8085 0 Td
(achieved)Tj
3.702 0 Td
(by)Tj
1.1792 0 Td
(chronically)Tj
4.6715 0 Td
(maintaining)Tj
5.1194 0 Td
(undetectable)Tj
5.3007 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(HIV-1)Tj
-33.732 -1.2983 Td
(RNA)Tj
2.262 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3732 0 Td
(plasma)Tj
3.0274 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.6044 0 Td
(The)Tj
1.7801 0 Td
(combination)Tj
5.3461 0 Td
(of)Tj
1.0148 0 Td
(three)Tj
2.2677 0 Td
(active)Tj
2.5228 0 Td
(agents)Tj
2.7496 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(first-line)Tj
3.6397 0 Td
(regimen)Tj
3.5376 0 Td
(is)Tj
-36.663 -1.3039 Td
(the)Tj
1.4683 0 Td
(standard)Tj
3.7247 0 Td
(of)Tj
1.0148 0 Td
(care)Tj
1.8708 0 Td
(to)Tj
1.0262 0 Td
(achieve)Tj
3.1748 0 Td
(this)Tj
1.6724 0 Td
(virological)Tj
4.4107 0 Td
(goal)Tj
1.8708 0 Td
(and)Tj
1.7291 0 Td
(nucleoside)Tj
4.4788 0 Td
(reverse)Tj
3.0443 0 Td
(transcriptase)Tj
5.3291 0 Td
(inhibi-)Tj
-34.8148 -1.2983 Td
(tors)Tj
1.7574 0 Td
(\(NRTIs\))Tj
3.5717 0 Td
(are)Tj
1.4456 0 Td
(the)Tj
1.4683 0 Td
(essential)Tj
3.583 0 Td
(component)Tj
4.8132 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1509 0 Td
(initial)Tj
2.5455 0 Td
(treatment)Tj
4.1385 0 Td
(strategies)Tj
3.9231 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
-28.2158 -1.2982 Td
(The)Tj
1.7858 0 Td
(long-term)Tj
4.2519 0 Td
(side)Tj
1.7972 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(NRTIs)Tj
2.8856 0 Td
(are)Tj
1.4514 0 Td
(still)Tj
1.6384 0 Td
(of)Tj
1.0148 0 Td
(concern.)Tj
3.6907 0 Td
(Some)Tj
2.4491 0 Td
(agents)Tj
2.7496 0 Td
(are)Tj
1.4456 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
-34.3556 -1.3039 Td
(renal)Tj
2.245 0 Td
(and)Tj
1.7291 0 Td
(bone)Tj
2.2053 0 Td
(toxicity)Tj
3.1975 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(],)Tj
2.5965 0 Td
(others)Tj
2.7099 0 Td
(with)Tj
1.9956 0 Td
(increased)Tj
4.0025 0 Td
(rates)Tj
2.109 0 Td
(of)Tj
1.0148 0 Td
(cardiovascular)Tj
5.998 0 Td
(events)Tj
2.7326 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5987 0 Td
(There-)Tj
-34.1345 -1.2983 Td
(fore,)Tj
2.0295 0 Td
(several)Tj
2.931 0 Td
(attempts)Tj
3.6681 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.1203 0 Td
(performed)Tj
4.4617 0 Td
(in)Tj
1.0375 0 Td
(order)Tj
2.4151 0 Td
(to)Tj
1.0204 0 Td
(test)Tj
1.5988 0 Td
(NRTI-sparing)Tj
5.8393 0 Td
(maintenance)Tj
5.3858 0 Td
(therapy)Tj
-34.5654 -1.2983 Td
(in)Tj
1.0318 0 Td
(virologically)Tj
5.1136 0 Td
(controlled)Tj
4.32 0 Td
(individuals)Tj
4.6488 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
3.0671 0 Td
(Maraviroc)Tj
4.3766 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(only)Tj
1.9729 0 Td
(CCR5)Tj
2.6476 0 Td
(\(R5\))Tj
1.9956 0 Td
(co-receptor)Tj
-31.4927 -1.2982 Td
(antagonist)Tj
4.3823 0 Td
(approved)Tj
3.9685 0 Td
(for)Tj
1.3889 0 Td
(use)Tj
1.5307 0 Td
(in)Tj
1.0375 0 Td
(patients)Tj
3.3675 0 Td
(carrying)Tj
3.5547 0 Td
(an)Tj
1.2018 0 Td
(R5-tropic)Tj
4.0536 0 Td
(virus)Tj
2.2053 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.075 0 Td
(Currently,)Tj
4.3483 0 Td
(the)Tj
1.4683 0 Td
(drug)Tj
2.1146 0 Td
(is)Tj
-36.697 -1.304 Td
(approved)Tj
3.9741 0 Td
(only)Tj
1.9729 0 Td
(for)Tj
1.389 0 Td
(patients)Tj
3.3675 0 Td
(failing)Tj
2.7326 0 Td
(previous)Tj
3.651 0 Td
(regimens,)Tj
4.1272 0 Td
(given)Tj
2.3754 0 Td
(its)Tj
1.1509 0 Td
(inferior)Tj
3.2598 0 Td
(efficacy)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(initial)Tj
2.5455 0 Td
(ther-)Tj
-34.7865 -1.2982 Td
(apy)Tj
1.627 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
3.5433 0 Td
(Nonetheless,)Tj
5.3008 0 Td
(agents)Tj
2.7496 0 Td
(with)Tj
2.0012 0 Td
(this)Tj
1.6724 0 Td
(mechanism)Tj
4.8416 0 Td
(of)Tj
1.0148 0 Td
(action)Tj
2.6985 0 Td
(should)Tj
2.9197 0 Td
(ideally)Tj
2.8176 0 Td
(be)Tj
1.1509 0 Td
(used)Tj
2.0636 0 Td
(early)Tj
-34.401 -1.2983 Td
(during)Tj
2.9253 0 Td
(treatment,)Tj
4.3596 0 Td
(before)Tj
2.744 0 Td
(the)Tj
1.4683 0 Td
(possible)Tj
3.4072 0 Td
(switch)Tj
2.7836 0 Td
(from)Tj
2.2054 0 Td
(R5)Tj
1.3209 0 Td
(to)Tj
1.0205 0 Td
(non-R5)Tj
3.2768 0 Td
(tropism)Tj
3.3562 0 Td
(at)Tj
0.9524 0 Td
(later)Tj
1.9956 0 Td
(stages)Tj
2.5625 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
-33.1821 -1.3039 Td
(The)Tj
1.7858 0 Td
(efficacy)Tj
3.2201 0 Td
(of)Tj
1.0148 0 Td
(maraviroc)Tj
4.303 0 Td
(as)Tj
1.0148 0 Td
(maintenance)Tj
5.3914 0 Td
(therapy)Tj
3.2429 0 Td
(in)Tj
1.0374 0 Td
(virologically)Tj
5.1137 0 Td
(controlled)Tj
4.3143 0 Td
(patients)Tj
3.3732 0 Td
(has)Tj
-35.0076 -1.2983 Td
(been)Tj
2.1203 0 Td
(recently)Tj
3.4128 0 Td
(tested)Tj
2.5512 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(MARCH)Tj
3.8494 0 Td
(study)Tj
2.3868 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.0806 0 Td
(In)Tj
1.1055 0 Td
(this)Tj
1.6725 0 Td
(large)Tj
2.1599 0 Td
(randomized)Tj
5.0627 0 Td
(study)Tj
2.3867 0 Td
(enrolling)Tj
3.8438 0 Td
(viro-)Tj
-35.138 -1.2982 Td
(logically)Tj
3.5092 0 Td
(controlled)Tj
4.32 0 Td
(patients)Tj
3.3675 0 Td
(on)Tj
1.2756 0 Td
(2)Tj
0.6973 0 Td
(NRTIs)Tj
2.8857 0 Td
(plus)Tj
1.8765 0 Td
(a)Tj
0.652 0 Td
(boosted)Tj
3.3505 0 Td
(protease)Tj
3.5546 0 Td
(inhibitor)Tj
3.7814 0 Td
(\(bPI\),)Tj
2.5342 0 Td
(substitution)Tj
4.9889 0 Td
(of)Tj
-36.7934 -1.3039 Td
(NRTIs)Tj
2.8913 0 Td
(with)Tj
1.9955 0 Td
(maraviroc)Tj
4.303 0 Td
(twice)Tj
2.3131 0 Td
(daily)Tj
2.1543 0 Td
(was)Tj
1.6951 0 Td
(inferior)Tj
3.2655 0 Td
(to)Tj
1.0261 0 Td
(continuing)Tj
4.6205 0 Td
(the)Tj
1.4683 0 Td
(baseline)Tj
3.4299 0 Td
(3-drug)Tj
2.9423 0 Td
(regimen.)Tj
3.7644 0 Td
(One)Tj
-35.8693 -1.2983 Td
(obstacle)Tj
3.4185 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(implementation)Tj
6.6387 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6724 0 Td
(strategy,)Tj
3.5546 0 Td
(the)Tj
1.4684 0 Td
(requirement)Tj
5.2043 0 Td
(of)Tj
1.0148 0 Td
(viral)Tj
1.99 0 Td
(tropism)Tj
3.3618 0 Td
(testing)Tj
2.8857 0 Td
(in)Tj
-34.7185 -1.2983 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(suppressed)Tj
4.6147 0 Td
(viremia,)Tj
3.481 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(overcome)Tj
4.1499 0 Td
(by)Tj
1.1849 0 Td
(genotypic)Tj
4.1215 0 Td
(tropism)Tj
3.3619 0 Td
(testing)Tj
2.8856 0 Td
(on)Tj
1.2756 0 Td
(viral)Tj
-34.1005 -1.3039 Td
(DNA)Tj
2.364 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0693 0 Td
(This)Tj
1.9786 0 Td
(strategy)Tj
3.3165 0 Td
(has)Tj
1.5307 0 Td
(now)Tj
1.9502 0 Td
(been)Tj
2.1146 0 Td
(validated)Tj
3.8211 0 Td
(retrospectively)Tj
6.0548 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(])Tj
3.3108 0 Td
(as)Tj
1.0035 0 Td
(well)Tj
1.8085 0 Td
(as)Tj
1.0091 0 Td
(prospectively)Tj
-32.3317 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.0692 0 Td
(The)Tj
1.7802 0 Td
(MARCH)Tj
3.8437 0 Td
(study)Tj
2.3811 0 Td
(was)Tj
1.6951 0 Td
(limited)Tj
3.0671 0 Td
(as)Tj
1.0091 0 Td
(the)Tj
1.4627 0 Td
(switch)Tj
2.7779 0 Td
(to)Tj
1.0205 0 Td
(maraviroc)Tj
4.2973 0 Td
(included)Tj
3.702 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.99 0 Td
(boosted)Tj
-34.4634 -1.2982 Td
(PI)Tj
1.1168 0 Td
(from)Tj
2.2053 0 Td
(older)Tj
2.2961 0 Td
(generations)Tj
4.8699 0 Td
(that)Tj
1.7801 0 Td
(were)Tj
2.1203 0 Td
(in)Tj
1.0375 0 Td
(most)Tj
2.2053 0 Td
(cases)Tj
2.2224 0 Td
(administered)Tj
5.4878 0 Td
(twice)Tj
2.3187 0 Td
(daily.)Tj
2.3755 0 Td
(Also,)Tj
2.2393 0 Td
(maraviroc)Tj
-32.275 -1.2983 Td
(was)Tj
1.6951 0 Td
(used)Tj
2.0636 0 Td
(twice)Tj
2.313 0 Td
(daily,)Tj
2.3754 0 Td
(which)Tj
2.6533 0 Td
(lacks)Tj
2.1826 0 Td
(convenience)Tj
5.2101 0 Td
(in)Tj
1.0374 0 Td
(terms)Tj
2.4888 0 Td
(of)Tj
1.0205 0 Td
(dosing)Tj
2.8913 0 Td
(and)Tj
1.7348 0 Td
(cost.)Tj
-26.4697 -1.3039 Td
(The)Tj
1.7858 0 Td
(aim)Tj
1.7404 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6725 0 Td
(study)Tj
2.3924 0 Td
(was)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(test)Tj
1.6044 0 Td
(non-inferiority)Tj
6.2362 0 Td
(of)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(NRTI-sparing)Tj
5.845 0 Td
(dual)Tj
1.9559 0 Td
(therapy)Tj
3.2485 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
-36.1018 -1.2983 Td
(once)Tj
2.1203 0 Td
(daily)Tj
2.1486 0 Td
(maraviroc)Tj
4.303 0 Td
(with)Tj
1.9955 0 Td
(darunavir/ritonavir)Tj
8.005 0 Td
(as)Tj
1.0092 0 Td
(compared)Tj
4.2462 0 Td
(to)Tj
1.0205 0 Td
(continuing)Tj
4.6261 0 Td
(an)Tj
1.1962 0 Td
(ongoing,)Tj
3.7531 0 Td
(virolog-)Tj
-34.4237 -1.2982 Td
(ically)Tj
2.2903 0 Td
(successful)Tj
4.1613 0 Td
(3-drug)Tj
2.9423 0 Td
(therapy.)Tj
3.4696 0 Td
(The)Tj
1.7801 0 Td
(experimental)Tj
5.4595 0 Td
(regimen)Tj
3.5376 0 Td
(tested)Tj
2.5569 0 Td
(here)Tj
1.9672 0 Td
(is)Tj
0.8447 0 Td
(not)Tj
1.5761 0 Td
(according)Tj
4.1839 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
-35.7956 -1.304 Td
(label)Tj
2.0749 0 Td
(of)Tj
1.0148 0 Td
(maraviroc.)Tj
4.5297 0 Td
(A)Tj
0.9014 0 Td
(secondary)Tj
4.2747 0 Td
(aim)Tj
1.7404 0 Td
(was)Tj
1.6951 0 Td
(to)Tj
1.0262 0 Td
(perform)Tj
3.5206 0 Td
(a)Tj
0.6519 0 Td
(prospective)Tj
4.7849 0 Td
(validation)Tj
4.2066 0 Td
(of)Tj
1.0148 0 Td
(selecting)Tj
-31.436 -1.2982 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(R5)Tj
1.3209 0 Td
(virus)Tj
2.1997 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(single-sequence)Tj
6.5196 0 Td
(viral)Tj
1.9956 0 Td
(DNA)Tj
2.3754 0 Td
(genotyping)Tj
4.7168 0 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 453.1464 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Switch)Tj
3.1181 0 Td
(to)Tj
1.0417 0 Td
(maraviro)Tj
3.8197 0 Td
(c)Tj
0.7158 0 Td
(with)Tj
1.963 0 Td
(darunavir/r)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01873)Tj
4.089 0 Td
(93)Tj
0 g
2.0906 0 Td
(November)Tj
4.7622 0 Td
(21,)Tj
1.5875 0 Td
(2017)Tj
32.5561 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(18)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Italy)Tj
1.7645 0 Td
(supported)Tj
3.9969 0 Td
(tropism)Tj
3.0969 0 Td
(testing)Tj
2.7142 0 Td
(for)Tj
1.2543 0 Td
(all)Tj
1.0276 0 Td
(patients)Tj
3.1323 0 Td
(for)Tj
-16.9867 -1.3748 Td
(conducting)Tj
4.3512 0 Td
(the)Tj
1.3677 0 Td
(study.)Tj
2.4945 0 Td
(ViiV)Tj
1.6512 0 Td
(Healthcare)Tj
4.1457 0 Td
(Italy)Tj
1.7717 0 Td
(also)Tj
-15.782 -1.3749 Td
(supported)Tj
3.9897 0 Td
(plasma)Tj
2.9056 0 Td
(antiretrovira)Tj
4.4504 0 Td
(l)Tj
0.4181 0 Td
(drug)Tj
1.9489 0 Td
(monitori)Tj
3.1181 0 Td
(ng)Tj
-16.8308 -1.3748 Td
(for)Tj
1.2543 0 Td
(patients)Tj
3.1394 0 Td
(in)Tj
0.8858 0 Td
(the)Tj
1.3677 0 Td
(study)Tj
2.2678 0 Td
(arm)Tj
1.7008 0 Td
(for)Tj
1.2543 0 Td
(conducting)Tj
4.3512 0 Td
(the)Tj
-16.2213 -1.3748 Td
(study.)Tj
2.4874 0 Td
(No)Tj
1.2827 0 Td
(additional)Tj
3.7913 0 Td
(external)Tj
3.1323 0 Td
(funding)Tj
3.0402 0 Td
(was)Tj
1.7008 0 Td
(received)Tj
-15.4347 -1.3748 Td
(for)Tj
1.2543 0 Td
(this)Tj
1.5661 0 Td
(study.)Tj
2.4875 0 Td
(The)Tj
1.5874 0 Td
(funders)Tj
3.0472 0 Td
(had)Tj
1.5875 0 Td
(no)Tj
1.1693 0 Td
(role)Tj
1.6157 0 Td
(in)Tj
0.8859 0 Td
(study)Tj
-15.2009 -1.3748 Td
(design,)Tj
2.8984 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7418 0 Td
(and)Tj
1.5874 0 Td
(analysis,)Tj
3.4087 0 Td
(decision)Tj
3.2953 0 Td
(to)Tj
-16.7245 -1.3748 Td
(publish,)Tj
3.1464 0 Td
(or)Tj
0.9993 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
/F7 1 Tf
-10.9063 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F8 1 Tf
0.4819 0 Td
(ADL)Tj
1.8001 0 Td
(reports)Tj
2.8842 0 Td
(consultin)Tj
3.3733 0 Td
(g)Tj
0.6945 0 Td
(fees)Tj
-16.9442 -1.3748 Td
(from)Tj
2.0126 0 Td
(Gilead)Tj
2.5086 0 Td
(Sciences)Tj
3.2953 0 Td
(,)Tj
0.4465 0 Td
(Abbvie,)Tj
2.9551 0 Td
(Janssen,)Tj
3.4938 0 Td
(Bristol-)Tj
-14.7119 -1.3749 Td
(Myers)Tj
2.5441 0 Td
(Squibb,)Tj
3.0543 0 Td
(ViiV)Tj
1.6583 0 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
1.9914 0 Td
(Merck)Tj
2.5441 0 Td
(Sharp)Tj
-15.9379 -1.3748 Td
(and)Tj
1.5874 0 Td
(Dohme,)Tj
3.1535 0 Td
(outside)Tj
2.9339 0 Td
(the)Tj
1.3677 0 Td
(submitted)Tj
3.9402 0 Td
(work.)Tj
2.289 0 Td
(SDG)Tj
-15.2717 -1.3748 Td
(reports)Tj
2.8771 0 Td
(consulting)Tj
4.0749 0 Td
(fees)Tj
1.7362 0 Td
(from)Tj
2.0126 0 Td
(Bristol-My)Tj
3.8481 0 Td
(ers)Tj
1.3748 0 Td
(Squibb,)Tj
-15.9237 -1.3748 Td
(Janssen)Tj
3.274 0 Td
(Cilag,)Tj
2.2536 0 Td
(ViiV)Tj
1.6511 0 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
1.9914 0 Td
(Gilead,)Tj
2.7355 0 Td
(Merck)Tj
-16.0513 -1.3748 Td
(Sharp)Tj
2.4236 0 Td
(and)Tj
1.5874 0 Td
(Dohme,)Tj
3.1536 0 Td
(outside)Tj
2.9268 0 Td
(the)Tj
1.3748 0 Td
(submitted)Tj
3.9402 0 Td
(work.)Tj
2.2819 0 Td
(BR)Tj
-17.6883 -1.3748 Td
(reports)Tj
2.8771 0 Td
(non-financial)Tj
4.9961 0 Td
(support)Tj
3.0969 0 Td
(from)Tj
2.0126 0 Td
(Janssen,)Tj
3.4938 0 Td
(ViiV)Tj
-16.4765 -1.3748 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
1.9913 0 Td
(Abbvie,)Tj
2.9481 0 Td
(Gilead,)Tj
2.7354 0 Td
(and)Tj
1.5874 0 Td
(consulting)Tj
-13.4079 -1.3748 Td
(fees)Tj
1.7362 0 Td
(from)Tj
2.0126 0 Td
(Merck)Tj
2.5441 0 Td
(Sharp)Tj
2.4237 0 Td
(and)Tj
1.5874 0 Td
(Dohme,)Tj
3.1535 0 Td
(outside)Tj
2.9339 0 Td
(the)Tj
-16.3914 -1.3749 Td
(submitted)Tj
3.9401 0 Td
(work.)Tj
2.289 0 Td
(AA)Tj
1.2685 0 Td
(reports)Tj
2.8772 0 Td
(grants,)Tj
2.7993 0 Td
(consulting)Tj
4.0677 0 Td
(fees)Tj
-17.2418 -1.3748 Td
(and)Tj
1.5874 0 Td
(non-financia)Tj
4.578 0 Td
(l)Tj
0.4181 0 Td
(support)Tj
3.0968 0 Td
(from)Tj
2.0056 0 Td
(Gilead)Tj
2.5157 0 Td
(Sciences)Tj
3.2953 0 Td
(,)Tj
-17.4969 -1.3748 Td
(Bristol-My)Tj
3.848 0 Td
(ers)Tj
1.3748 0 Td
(Squibb,)Tj
3.0544 0 Td
(ViiV)Tj
1.6583 0 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
1.9913 0 Td
(grants)Tj
-16.0725 -1.3748 Td
(and)Tj
1.5874 0 Td
(consulting)Tj
4.0748 0 Td
(fees)Tj
1.7362 0 Td
(from)Tj
2.0126 0 Td
(Janssen)Tj
3.2741 0 Td
(Cilag,)Tj
2.2465 0 Td
(consulting)Tj
-14.9316 -1.3748 Td
(fees)Tj
1.7362 0 Td
(and)Tj
1.5945 0 Td
(non-fin)Tj
2.6433 0 Td
(ancial)Tj
2.3457 0 Td
(support)Tj
3.0969 0 Td
(from)Tj
2.0126 0 Td
(Abbvie,)Tj
-13.4292 -1.3748 Td
(consulting)Tj
4.0748 0 Td
(fees)Tj
1.7362 0 Td
(from)Tj
2.0126 0 Td
(Merck,)Tj
2.7638 0 Td
(outside)Tj
2.9339 0 Td
(the)Tj
1.3677 0 Td
(submitted)Tj
-14.889 -1.3819 Td
(work.)Tj
2.2889 0 Td
(ADM)Tj
2.0835 0 Td
(reports)Tj
2.8772 0 Td
(grants)Tj
2.5725 0 Td
(and)Tj
1.5874 0 Td
(consulting)Tj
4.0748 0 Td
(fees)Tj
-15.4843 -1.3748 Td
(from)Tj
2.0126 0 Td
(Bristol-My)Tj
3.848 0 Td
(ers)Tj
1.3678 0 Td
(Squibb,)Tj
3.0614 0 Td
(Merck)Tj
2.5441 0 Td
(Sharp)Tj
2.4237 0 Td
(and)Tj
-15.2576 -1.3749 Td
(Dohme)Tj
2.9267 0 Td
(Gilead,)Tj
2.7355 0 Td
(consulting)Tj
4.0748 0 Td
(fees)Tj
1.7363 0 Td
(from)Tj
2.0126 0 Td
(ViiV)Tj
-13.4859 -1.3748 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
1.9913 0 Td
(outside)Tj
2.9268 0 Td
(the)Tj
1.3748 0 Td
(submitt)Tj
2.8205 0 Td
(ed)Tj
1.1197 0 Td
(work.)Tj
2.2819 0 Td
(CM)Tj
-16.6607 -1.3748 Td
(reports)Tj
2.8771 0 Td
(consulting)Tj
4.0749 0 Td
(fees)Tj
1.7362 0 Td
(and)Tj
1.5874 0 Td
(non-financial)Tj
4.9961 0 Td
(support)Tj
-15.2717 -1.3748 Td
(from)Tj
2.0126 0 Td
(ABBVIE,)Tj
3.274 0 Td
(consultin)Tj
3.3733 0 Td
(g)Tj
0.6945 0 Td
(fees)Tj
1.7433 0 Td
(from)Tj
2.0055 0 Td
(Merck)Tj
2.5441 0 Td
(Sharp)Tj
-15.6473 -1.3748 Td
(and)Tj
1.5874 0 Td
(Dohme,)Tj
3.1535 0 Td
(Gilead)Tj
2.5087 0 Td
(Sciences,)Tj
3.7489 0 Td
(ViiV)Tj
1.6512 0 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
-16.7954 -1.3748 Td
(BMS,)Tj
2.2464 0 Td
(non-financial)Tj
4.9961 0 Td
(support)Tj
3.0969 0 Td
(from)Tj
2.0126 0 Td
(ASTELLA)Tj
3.4654 0 Td
(S,)Tj
-15.8174 -1.3748 Td
(outside)Tj
2.9338 0 Td
(the)Tj
1.3678 0 Td
(submitted)Tj
3.9401 0 Td
(work.)Tj
2.289 0 Td
(FV)Tj
1.1623 0 Td
(reports)Tj
2.8842 0 Td
(non-)Tj
-14.5772 -1.3749 Td
(financial)Tj
3.2669 0 Td
(support)Tj
3.0969 0 Td
(from)Tj
2.0126 0 Td
(Bristol-My)Tj
3.8481 0 Td
(ers)Tj
1.3677 0 Td
(Squibb,)Tj
3.0614 0 Td
(ViiV)Tj
-16.6536 -1.3748 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
1.9913 0 Td
(Gilead)Tj
2.5087 0 Td
(Sciences)Tj
3.2953 0 Td
(,)Tj
0.4464 0 Td
(consulting)Tj
4.0749 0 Td
(fees)Tj
-16.4623 -1.3748 Td
(from)Tj
2.0126 0 Td
(Merck)Tj
2.5441 0 Td
(Sharp)Tj
2.4165 0 Td
(and)Tj
1.5945 0 Td
(Dohme,)Tj
3.1536 0 Td
(BMS,)Tj
2.2465 0 Td
(outside)Tj
2.9339 0 Td
(the)Tj
-16.9017 -1.3748 Td
(submitted)Tj
3.9401 0 Td
(work.)Tj
2.289 0 Td
(MC)Tj
1.4953 0 Td
(reports)Tj
2.8843 0 Td
(consulti)Tj
2.8984 0 Td
(ng)Tj
1.1693 0 Td
(fees)Tj
1.7434 0 Td
(from)Tj
-16.4198 -1.3748 Td
(Gilead)Tj
2.5086 0 Td
(Sciences,)Tj
3.7418 0 Td
(Janssen-Cilag,)Tj
5.6126 0 Td
(Merck)Tj
2.5512 0 Td
(Sharp)Tj
2.4166 0 Td
(and)Tj
-16.8308 -1.3748 Td
(Dohme,)Tj
3.1535 0 Td
(Bristol-Myer)Tj
4.578 0 Td
(s)Tj
0.6449 0 Td
(Squibb,)Tj
3.0543 0 Td
(ViiV)Tj
1.6583 0 Td
(Healthcare)Tj
-13.089 -1.3748 Td
(Italy,)Tj
1.9913 0 Td
(outside)Tj
2.9339 0 Td
(the)Tj
1.3677 0 Td
(submitted)Tj
3.9402 0 Td
(work.)Tj
2.289 0 Td
(MZ)Tj
1.4457 0 Td
(reports)Tj
-13.9678 -1.3749 Td
(grants)Tj
2.5724 0 Td
(and)Tj
1.5874 0 Td
(consulting)Tj
4.0749 0 Td
(fees)Tj
1.7362 0 Td
(from)Tj
2.0126 0 Td
(ViiV)Tj
1.6583 0 Td
(Health)Tj
2.3457 0 Td
(care)Tj
-15.9875 -1.3748 Td
(Italy,)Tj
1.9913 0 Td
(Janssen-C)Tj
3.8835 0 Td
(ilag,)Tj
1.7291 0 Td
(Gilead)Tj
2.5087 0 Td
(Sciences,)Tj
3.7418 0 Td
(outside)Tj
2.9339 0 Td
(the)Tj
-16.7883 -1.3748 Td
(submitted)Tj
3.9401 0 Td
(work.)Tj
2.289 0 Td
(SR)Tj
1.3323 0 Td
(reports)Tj
2.8772 0 Td
(grants)Tj
2.5725 0 Td
(and)Tj
1.5874 0 Td
(consulting)Tj
-14.5985 -1.3748 Td
(fees)Tj
1.7362 0 Td
(from)Tj
2.0126 0 Td
(ViiV)Tj
1.6583 0 Td
(Healthcare)Tj
4.1457 0 Td
(Italy,)Tj
1.9913 0 Td
(Bristol-My)Tj
3.8481 0 Td
(ers)Tj
-15.3922 -1.3748 Td
(Squibb,)Tj
3.0543 0 Td
(Merck)Tj
2.5441 0 Td
(Sharp)Tj
2.4237 0 Td
(and)Tj
1.5874 0 Td
(Dohme,)Tj
3.1535 0 Td
(Gilead)Tj
2.5087 0 Td
(Sciences,)Tj
-15.2717 -1.3748 Td
(Janssen,)Tj
3.5008 0 Td
(outside)Tj
2.9268 0 Td
(the)Tj
1.3748 0 Td
(submitt)Tj
2.8205 0 Td
(ed)Tj
1.1197 0 Td
(work.)Tj
2.2819 0 Td
(All)Tj
1.1338 0 Td
(other)Tj
-15.1583 -1.3748 Td
(authors)Tj
3.0472 0 Td
(have)Tj
1.9559 0 Td
(nothing)Tj
3.0331 0 Td
(to)Tj
ET
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
BT
8.9858 20.0907 Td
(disclose.)Tj
ET
Q
endstream
endobj
53 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 56 0 R/Contents 57 0 R/TrimBox[0 0 612 792]>>
endobj
56 0 obj
[58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R]
endobj
58 0 obj
<>/Border[0 0 0]/A 64 0 R>>
endobj
64 0 obj
<>
endobj
59 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref022)>>
endobj
60 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref023)>>
endobj
61 0 obj
<>/Border[0 0 0]/A 65 0 R>>
endobj
65 0 obj
<>
endobj
62 0 obj
<>/Border[0 0 0]/A 66 0 R>>
endobj
66 0 obj
<>
endobj
63 0 obj
<>/Border[0 0 0]/A 67 0 R>>
endobj
67 0 obj
<>
endobj
57 0 obj
[68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R]
endobj
68 0 obj
<>stream
q
0.83 0.64 0.02 0 k
317.1402 657.0142 m
406.3181 657.0142 l
h
f*
203.5276 172.9134 m
213.2787 172.9134 l
h
f*
321.7323 120.926 m
331.5402 120.926 l
h
f*
267.5906 107.9433 m
316.4598 107.9433 l
h
f*
399.1181 107.9433 m
525.8268 107.9433 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Methods)Tj
/F0 1 Tf
0 -1.4976 Td
(Study)Tj
2.7543 0 Td
(design,)Tj
3.4016 0 Td
(inclusion)Tj
4.0489 0 Td
(and)Tj
1.8661 0 Td
(exclusion)Tj
4.3323 0 Td
(criteria)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 671.074 cm
BT
/F6 1 Tf
1 TL
0.003 Tc
0 0 Td
(GUSTA)Tj
3.4752 0 Td
(\(GUided)Tj
3.8097 0 Td
(Simplification)Tj
5.9414 0 Td
(with)Tj
2.0239 0 Td
(Tropism)Tj
3.7247 0 Td
(Assay\))Tj
2.897 0 Td
(was)Tj
1.7235 0 Td
(a)Tj
0.6576 0 Td
(multicenter,)Tj
5.1761 0 Td
(open-label,)Tj
4.7281 0 Td
(ran-)Tj
-34.1572 -1.2982 Td
(domized)Tj
3.753 0 Td
(study)Tj
2.4264 0 Td
(\(registered)Tj
4.5695 0 Td
(at)Tj
0.83 0.64 0.02 0 k
0.9637 0 Td
(www.clinicaltrials.gov)Tj
0 g
(,)Tj
9.3713 0 Td
(number)Tj
3.4583 0 Td
(NCT01367210\).)Tj
6.6953 0 Td
(The)Tj
1.8029 0 Td
(study)Tj
2.4264 0 Td
(pro-)Tj
-35.4668 -1.3039 Td
(tocol)Tj
2.2336 0 Td
(was)Tj
1.7235 0 Td
(authorized)Tj
4.5864 0 Td
(by)Tj
1.1962 0 Td
(the)Tj
1.491 0 Td
(Italian)Tj
2.8347 0 Td
(Drug)Tj
2.347 0 Td
(Regulatory)Tj
4.6432 0 Td
(Agency)Tj
3.2598 0 Td
(\(AIFA\))Tj
3.1804 0 Td
(and)Tj
1.7518 0 Td
(approved)Tj
4.0252 0 Td
(by)Tj
1.1962 0 Td
(the)Tj
-34.469 -1.2983 Td
(local)Tj
2.1089 0 Td
(Ethics)Tj
2.7099 0 Td
(Committees)Tj
5.1704 0 Td
(at)Tj
0.9694 0 Td
(each)Tj
2.058 0 Td
(study)Tj
2.4207 0 Td
(center;)Tj
2.9821 0 Td
(written)Tj
3.1634 0 Td
(informed)Tj
4.0308 0 Td
(consent)Tj
3.3789 0 Td
(was)Tj
1.7178 0 Td
(obtained)Tj
3.7871 0 Td
(from)Tj
-34.4974 -1.2983 Td
(all)Tj
1.1678 0 Td
(patients)Tj
3.4242 0 Td
(before)Tj
2.778 0 Td
(participation.)Tj
5.6976 0 Td
(The)Tj
1.8028 0 Td
(study)Tj
2.4264 0 Td
(was)Tj
1.7178 0 Td
(performed)Tj
4.5298 0 Td
(in)Tj
1.0545 0 Td
(accordance)Tj
4.8018 0 Td
(with)Tj
2.0296 0 Td
(the)Tj
1.491 0 Td
(ethical)Tj
-32.9213 -1.2982 Td
(guidelines)Tj
4.3483 0 Td
(of)Tj
1.0261 0 Td
(the)Tj
1.491 0 Td
(Declaration)Tj
4.989 0 Td
(of)Tj
1.0261 0 Td
(Helsinki)Tj
3.6567 0 Td
(\(7th)Tj
1.8878 0 Td
(revision\))Tj
3.8211 0 Td
(and)Tj
1.7518 0 Td
(with)Tj
2.0239 0 Td
(the)Tj
1.491 0 Td
(International)Tj
5.5786 0 Td
(Confer-)Tj
-33.0914 -1.3039 Td
(ence)Tj
2.0636 0 Td
(on)Tj
1.2925 0 Td
(Harmonization)Tj
6.4913 0 Td
(Good)Tj
2.5059 0 Td
(Clinical)Tj
3.3732 0 Td
(Practice)Tj
3.4752 0 Td
(guidelines.)Tj
4.5808 0 Td
(The)Tj
1.8028 0 Td
(authors)Tj
3.2995 0 Td
(confirm)Tj
3.4923 0 Td
(that)Tj
1.8028 0 Td
(all)Tj
-34.1799 -1.2983 Td
(related)Tj
2.9933 0 Td
(trials)Tj
2.2394 0 Td
(for)Tj
1.4059 0 Td
(this)Tj
1.7008 0 Td
(intervention)Tj
5.2611 0 Td
(are)Tj
1.474 0 Td
(registered.)Tj
4.4504 0 Td
(Study)Tj
2.5398 0 Td
(approval)Tj
3.7587 0 Td
(by)Tj
1.1962 0 Td
(the)Tj
1.491 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8019 0 Td
(of)Tj
-36.0224 -1.2983 Td
(the)Tj
1.491 0 Td
(Catholic)Tj
3.6396 0 Td
(University)Tj
4.4731 0 Td
(was)Tj
1.7234 0 Td
(obtained)Tj
3.7871 0 Td
(on)Tj
1.2869 0 Td
(November)Tj
4.5241 0 Td
(18,)Tj
1.4173 0 Td
(2010.)Tj
2.3811 0 Td
(Between)Tj
3.651 0 Td
(May)Tj
2.0239 0 Td
(23,)Tj
1.4173 0 Td
(2011)Tj
2.1487 0 Td
(and)Tj
-33.9645 -1.3039 Td
(April)Tj
2.3414 0 Td
(22,)Tj
1.4173 0 Td
(2015,)Tj
2.3811 0 Td
(patients)Tj
3.4242 0 Td
(underwent)Tj
4.6374 0 Td
(screening)Tj
4.1159 0 Td
(for)Tj
1.406 0 Td
(the)Tj
1.491 0 Td
(study)Tj
2.4264 0 Td
(and)Tj
1.7518 0 Td
(the)Tj
1.4854 0 Td
(latest)Tj
2.3244 0 Td
(visit)Tj
1.9049 0 Td
(was)Tj
1.7177 0 Td
(on)Tj
1.2926 0 Td
(Septem-)Tj
-34.1175 -1.2983 Td
(ber)Tj
1.542 0 Td
(28,)Tj
1.4116 0 Td
(2015.)Tj
2.3811 0 Td
(The)Tj
1.8028 0 Td
(complete)Tj
3.9345 0 Td
(list)Tj
1.4173 0 Td
(of)Tj
1.0262 0 Td
(Ethics)Tj
2.7099 0 Td
(Committes)Tj
4.7395 0 Td
(that)Tj
1.8028 0 Td
(approved)Tj
4.0252 0 Td
(study)Tj
2.4264 0 Td
(is:)Tj
1.0942 0 Td
(Ethics)Tj
2.7042 0 Td
(Committee)Tj
-33.0177 -1.2982 Td
(of)Tj
1.0261 0 Td
(Umbria)Tj
3.3959 0 Td
(and)Tj
1.7518 0 Td
(Perugia;)Tj
3.5489 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8076 0 Td
(of)Tj
1.0261 0 Td
(Azienda)Tj
3.566 0 Td
(Ospedaliera)Tj
5.0513 0 Td
(Sacco,)Tj
2.7495 0 Td
(Milan;)Tj
2.8744 0 Td
(Ethics)Tj
2.7099 0 Td
(Com-)Tj
-35.2174 -1.3039 Td
(mittee)Tj
2.7892 0 Td
(of)Tj
1.0318 0 Td
(Modena;)Tj
3.8268 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8018 0 Td
(Azienda)Tj
3.566 0 Td
(Ospedaliero-Univers)Tj
8.4755 0 Td
(itaria)Tj
2.3301 0 Td
(of)Tj
1.0318 0 Td
(Florence;)Tj
3.9798 0 Td
(Ethics)Tj
-34.5427 -1.2983 Td
(Committee)Tj
4.8018 0 Td
(University)Tj
4.4731 0 Td
(of)Tj
1.0261 0 Td
(Study)Tj
2.5398 0 Td
(D'Annunzio)Tj
5.2894 0 Td
(and)Tj
1.7518 0 Td
(Chieti;)Tj
2.9424 0 Td
(Ethics)Tj
2.7042 0 Td
(Committee)Tj
4.8075 0 Td
(AUSL)Tj
2.6816 0 Td
(9)Tj
0.703 0 Td
(of)Tj
1.0261 0 Td
(Gros-)Tj
-34.7468 -1.2983 Td
(seto;)Tj
2.0692 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8019 0 Td
(Azienda)Tj
3.566 0 Td
(Ospedaliera)Tj
5.0513 0 Td
(Universitaria)Tj
5.5445 0 Td
(S)Tj
0.703 0 Td
(Martino,)Tj
3.8211 0 Td
(Genova;)Tj
3.5773 0 Td
(Ethics)Tj
2.7099 0 Td
(Com-)Tj
-34.5541 -1.2982 Td
(mittee)Tj
2.7892 0 Td
(AUSL)Tj
2.6816 0 Td
(3)Tj
0.703 0 Td
(Pistoia;)Tj
3.1974 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8019 0 Td
(Azienda)Tj
3.566 0 Td
(Ospedaliera)Tj
5.0513 0 Td
(S.)Tj
0.9354 0 Td
(Salvatore)Tj
3.9288 0 Td
(of)Tj
1.0261 0 Td
(Pesaro;)Tj
3.1521 0 Td
(Ethics)Tj
-34.5427 -1.3039 Td
(Committee)Tj
4.8018 0 Td
(AOU)Tj
2.4094 0 Td
(San)Tj
1.7008 0 Td
(Luigi)Tj
2.3187 0 Td
(Gonzaga)Tj
3.7871 0 Td
(of)Tj
1.0261 0 Td
(Orbassano;)Tj
4.7849 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8019 0 Td
(Azienda)Tj
3.5716 0 Td
(Ospedaliero-)Tj
-31.9122 -1.2983 Td
(Universitaria)Tj
5.5445 0 Td
(Policlinico)Tj
4.5581 0 Td
(S.)Tj
0.9354 0 Td
(Orsola-Malpighi)Tj
6.9562 0 Td
(of)Tj
1.0318 0 Td
(Bologna;)Tj
3.787 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8019 0 Td
(IRCC)Tj
2.5398 0 Td
(of)Tj
1.0262 0 Td
(Rome;)Tj
-33.8908 -1.2983 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8018 0 Td
(of)Tj
1.0261 0 Td
(Lecce;)Tj
2.7213 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8019 0 Td
(Policlinico)Tj
4.558 0 Td
(Umberto)Tj
3.9345 0 Td
(I)Tj
0.5669 0 Td
(of)Tj
1.0262 0 Td
(Rome;)Tj
2.8573 0 Td
(Ethics)Tj
2.7042 0 Td
(Com-)Tj
-34.418 -1.3039 Td
(mittee)Tj
2.7892 0 Td
(Lazio)Tj
2.4151 0 Td
(2;)Tj
0.9355 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8018 0 Td
(IRCC)Tj
2.5398 0 Td
(Spallanzani)Tj
4.8586 0 Td
(of)Tj
1.0318 0 Td
(Rome;)Tj
2.8516 0 Td
(Ethics)Tj
2.7099 0 Td
(Committee)Tj
4.8019 0 Td
(San)Tj
1.7008 0 Td
(Paolo)Tj
-34.1459 -1.2983 Td
(Hospital,)Tj
3.9061 0 Td
(Milano.)Tj
-0.004 Tc
-2.7099 -1.2982 Td
(Eligible)Tj
3.2144 0 Td
(patients)Tj
3.3676 0 Td
(were)Tj
2.1203 0 Td
(HIV-1-infected,)Tj
6.6273 0 Td
(aged)Tj
/F10 1 Tf
0 Tc
2.0693 0 Td
()Tj
/F6 1 Tf
-0.004 Tc
(18)Tj
1.9446 0 Td
(years,)Tj
2.4888 0 Td
(treated)Tj
2.999 0 Td
(with)Tj
1.9956 0 Td
(any)Tj
1.6554 0 Td
(ART)Tj
2.1373 0 Td
(regimen)Tj
-31.8158 -1.3039 Td
(including)Tj
4.0421 0 Td
(3)Tj
0.6917 0 Td
(drugs)Tj
2.4774 0 Td
(without)Tj
3.3279 0 Td
(treatment)Tj
4.1386 0 Td
(changes)Tj
3.4015 0 Td
(during)Tj
2.9253 0 Td
(the)Tj
1.474 0 Td
(last)Tj
1.5591 0 Td
(3)Tj
0.6916 0 Td
(months,)Tj
3.5093 0 Td
(with)Tj
1.9956 0 Td
(HIV-1)Tj
2.8516 0 Td
(RNA)Tj
/F11 1 Tf
0 Tc
2.2621 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
(50)Tj
-35.3478 -1.2983 Td
(copies/mL)Tj
4.405 0 Td
(for)Tj
1.3889 0 Td
(at)Tj
0.9525 0 Td
(least)Tj
1.9785 0 Td
(6)Tj
0.6974 0 Td
(months)Tj
3.2825 0 Td
(on)Tj
1.2755 0 Td
(two)Tj
1.7065 0 Td
(consecutive)Tj
4.8812 0 Td
(determinations,)Tj
6.5423 0 Td
(with)Tj
1.9956 0 Td
(CD4)Tj
2.0976 0 Td
(cell)Tj
1.5591 0 Td
(count)Tj
/F11 1 Tf
0 Tc
2.5228 0 Td
(>)Tj
/F6 1 Tf
-0.004 Tc
(200)Tj
-35.2854 -1.2983 Td
(cells/mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 236.6929 363.5149 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 242.4755 359.0929 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(for)Tj
1.3832 0 Td
(at)Tj
0.9525 0 Td
(least)Tj
1.9842 0 Td
(3)Tj
0.6973 0 Td
(months,)Tj
3.5036 0 Td
(and)Tj
1.7292 0 Td
(with)Tj
2.0012 0 Td
(R5)Tj
1.3153 0 Td
(virus.)Tj
-16.6165 -1.3039 Td
(Main)Tj
2.3641 0 Td
(exclusion)Tj
3.991 0 Td
(criteria)Tj
3.0728 0 Td
(were)Tj
2.1259 0 Td
(having)Tj
2.914 0 Td
(a)Tj
0.6577 0 Td
(CD4)Tj
2.0919 0 Td
(cell)Tj
1.5591 0 Td
(count)Tj
2.5285 0 Td
(at)Tj
0.9524 0 Td
(nadir)Tj
/F11 1 Tf
0 Tc
2.3697 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
(50)Tj
1.9389 0 Td
(cell/mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 510.7464 350.5322 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 516.4724 346.0535 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(or)Tj
/F11 1 Tf
0 Tc
1.0998 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
(100)Tj
2.4208 0 Td
(cell/)Tj
-35.1663 -1.2982 Td
(mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 216.3968 337.5496 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 222.1228 333.0708 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(in)Tj
1.0374 0 Td
(case)Tj
1.8595 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(history)Tj
3.0047 0 Td
(of)Tj
1.0148 0 Td
(virological)Tj
4.405 0 Td
(failure)Tj
2.7779 0 Td
(with)Tj
1.9956 0 Td
(PI,)Tj
1.3436 0 Td
(past)Tj
1.8312 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(maraviroc,)Tj
4.5241 0 Td
(pregnancy,)Tj
4.6318 0 Td
(breast-)Tj
-34.8489 -1.2982 Td
(feeding)Tj
3.1634 0 Td
(status,)Tj
2.7269 0 Td
(positive)Tj
3.3108 0 Td
(serum)Tj
2.727 0 Td
(hepatitis)Tj
3.6113 0 Td
(B)Tj
0.7993 0 Td
(virus)Tj
2.2054 0 Td
(surface)Tj
3.05 0 Td
(antigen,)Tj
3.4299 0 Td
(a)Tj
0.652 0 Td
(history)Tj
3.0104 0 Td
(of)Tj
1.0148 0 Td
(major)Tj
2.6078 0 Td
(toxicity)Tj
3.1975 0 Td
(to)Tj
-35.5065 -1.2983 Td
(any)Tj
1.6555 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3924 0 Td
(or)Tj
1.0999 0 Td
(current)Tj
3.1804 0 Td
(drugs,)Tj
2.6986 0 Td
(AIDS-related)Tj
5.5332 0 Td
(events)Tj
2.7269 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(year)Tj
1.9049 0 Td
(before)Tj
2.7382 0 Td
(screening,)Tj
4.2803 0 Td
(liver)Tj
1.9842 0 Td
(cir-)Tj
-35.1833 -1.3039 Td
(rhosis,)Tj
2.8402 0 Td
(eGFR)Tj
/F11 1 Tf
0 Tc
2.5058 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
(30)Tj
1.9446 0 Td
(mL/min)Tj
3.5433 0 Td
(and)Tj
1.7291 0 Td
(grade)Tj
2.4435 0 Td
(IV)Tj
1.2529 0 Td
(ALT)Tj
2.0522 0 Td
(or)Tj
1.0999 0 Td
(AST)Tj
1.9899 0 Td
(elevation.)Tj
4.0478 0 Td
(Previous)Tj
3.6907 0 Td
(virological)Tj
4.4107 0 Td
(failures)Tj
-33.5506 -1.2983 Td
(were)Tj
2.1203 0 Td
(allowed,)Tj
3.5149 0 Td
(but)Tj
1.5534 0 Td
(previous)Tj
3.651 0 Td
(failures)Tj
3.1351 0 Td
(to)Tj
1.0261 0 Td
(enfuvirtide)Tj
4.6204 0 Td
(or)Tj
1.0942 0 Td
(integrase)Tj
3.8154 0 Td
(inhibitors)Tj
4.1442 0 Td
(and)Tj
1.7292 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(at)Tj
-35.7673 -1.2982 Td
(least)Tj
1.9843 0 Td
(one)Tj
1.695 0 Td
(major)Tj
2.6078 0 Td
(or)Tj
1.0999 0 Td
(two)Tj
1.7121 0 Td
(minor)Tj
2.7326 0 Td
(darunavir)Tj
4.1555 0 Td
(resistance)Tj
4.1329 0 Td
(mutations)Tj
4.2803 0 Td
(\(last)Tj
1.8992 0 Td
(available)Tj
3.668 0 Td
(IAS-USA)Tj
3.9628 0 Td
(list\))Tj
1.7348 0 Td
(were)Tj
-35.6652 -1.3039 Td
(excluded.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 217.0204 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Determination)Tj
6.3685 0 Td
(of)Tj
1.0441 0 Td
(viral)Tj
2.0268 0 Td
(tropism)Tj
3.463 0 Td
(and)Tj
1.8662 0 Td
(resistance)Tj
4.7244 0 Td
(testing)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 200.0125 cm
BT
/F6 1 Tf
1 TL
0.009 Tc
0 0 Td
(All)Tj
1.4343 0 Td
(patients)Tj
3.4696 0 Td
(underwent)Tj
4.6941 0 Td
(genotypic)Tj
4.2406 0 Td
(testing)Tj
2.9764 0 Td
(for)Tj
1.4229 0 Td
(HIV-1)Tj
2.914 0 Td
(coreceptor)Tj
4.6148 0 Td
(tropism)Tj
3.4526 0 Td
(at)Tj
0.9808 0 Td
(screening)Tj
4.1669 0 Td
(by)Tj
1.2075 0 Td
(pop-)Tj
-35.5745 -1.3039 Td
(ulation)Tj
3.135 0 Td
(sequencing)Tj
4.8416 0 Td
(on)Tj
1.2983 0 Td
(whole)Tj
2.6702 0 Td
(blood)Tj
2.5795 0 Td
(using)Tj
2.4491 0 Td
(a)Tj
0.6633 0 Td
(single)Tj
2.6079 0 Td
(DNA)Tj
2.4151 0 Td
(sequence)Tj
3.9571 0 Td
(of)Tj
1.0375 0 Td
(the)Tj
1.508 0 Td
(gp120)Tj
2.6872 0 Td
(V3)Tj
1.4117 0 Td
(env)Tj
1.6837 0 Td
(region)Tj
-34.9452 -1.2982 Td
([)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
2.1429 0 Td
(DNA)Tj
2.4151 0 Td
(sequence)Tj
3.9628 0 Td
(retesting)Tj
3.7928 0 Td
(was)Tj
1.7348 0 Td
(allowed)Tj
3.3845 0 Td
(a)Tj
0.6633 0 Td
(maximum)Tj
4.4674 0 Td
(of)Tj
1.0375 0 Td
(three)Tj
2.33 0 Td
(times)Tj
2.4548 0 Td
(in)Tj
1.0602 0 Td
(case)Tj
1.9162 0 Td
(of)Tj
1.0431 0 Td
(amplifica-)Tj
-32.4054 -1.2983 Td
(tion)Tj
1.8935 0 Td
(failure.)Tj
3.1067 0 Td
(Results)Tj
3.1465 0 Td
(were)Tj
2.177 0 Td
(interpreted)Tj
4.8358 0 Td
(using)Tj
2.4548 0 Td
(the)Tj
1.508 0 Td
(geno2pheno)Tj
5.2951 0 Td
(prediction)Tj
4.5014 0 Td
(algorithm.)Tj
4.5071 0 Td
(A)Tj
0.9184 0 Td
(false)Tj
-34.3443 -1.2983 Td
(positive)Tj
3.4185 0 Td
(rate)Tj
1.7972 0 Td
(\(FPR\))Tj
2.6759 0 Td
(higher)Tj
2.8799 0 Td
(than)Tj
2.0807 0 Td
(10%)Tj
1.9672 0 Td
(indicated)Tj
4.0535 0 Td
(an)Tj
1.2302 0 Td
(R5)Tj
1.3436 0 Td
(virus.)Tj
2.5059 0 Td
(The)Tj
1.8198 0 Td
(genotyping)Tj
4.8472 0 Td
(was)Tj
1.7348 0 Td
(performed)Tj
-32.3544 -1.3039 Td
(at)Tj
0.9751 0 Td
(virological)Tj
4.5524 0 Td
(laboratories)Tj
5.108 0 Td
(that)Tj
1.8255 0 Td
(had)Tj
1.7518 0 Td
(been)Tj
2.1713 0 Td
(certified)Tj
3.6283 0 Td
(by)Tj
1.2076 0 Td
(a)Tj
0.6689 0 Td
(national)Tj
3.6057 0 Td
(QC/QA)Tj
3.4582 0 Td
(program)Tj
3.7928 0 Td
(for)Tj
1.4286 0 Td
(geno-)Tj
-34.1742 -1.2982 Td
(typic)Tj
2.245 0 Td
(tropism)Tj
3.4526 0 Td
(determination)Tj
6.1227 0 Td
([)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(].)Tj
2.143 0 Td
(The)Tj
1.8199 0 Td
(genotypic)Tj
4.2462 0 Td
(HIV-1)Tj
2.9084 0 Td
(coreceptor)Tj
4.6204 0 Td
(tropism)Tj
3.4526 0 Td
(assay)Tj
2.33 0 Td
(has)Tj
1.5818 0 Td
(been)Tj
-34.9226 -1.2983 Td
(deposited)Tj
4.1895 0 Td
(in)Tj
1.0602 0 Td
(the)Tj
0.83 0.64 0.02 0 k
1.508 0 Td
(protocols.io)Tj
0 g
5.1137 0 Td
(repository)Tj
4.4277 0 Td
(with)Tj
2.0522 0 Td
(doi)Tj
0.83 0.64 0.02 0 k
1.5591 0 Td
(10.17504/protocols.i)Tj
8.3791 0 Td
(o.jmnck5e)Tj
0 g
(.)Tj
4.7509 0 Td
(Genotypic)Tj
-33.0404 -1.3039 Td
(resistance)Tj
4.2632 0 Td
(to)Tj
1.0488 0 Td
(NRTIs,)Tj
3.1918 0 Td
(NNRTIs)Tj
3.7077 0 Td
(and)Tj
1.7688 0 Td
(PIs)Tj
1.5194 0 Td
(was)Tj
1.7348 0 Td
(determined)Tj
4.9833 0 Td
(using)Tj
2.4548 0 Td
(the)Tj
1.508 0 Td
(Viroseq)Tj
3.4412 0 Td
(HIV-1)Tj
2.914 0 Td
(Genotyping)Tj
-32.5358 -1.2983 Td
(System.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 453.1464 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Switch)Tj
3.1181 0 Td
(to)Tj
1.0417 0 Td
(maraviro)Tj
3.8197 0 Td
(c)Tj
0.7158 0 Td
(with)Tj
1.963 0 Td
(darunavir/r)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01873)Tj
4.089 0 Td
(93)Tj
0 g
2.0906 0 Td
(November)Tj
4.7622 0 Td
(21,)Tj
1.5875 0 Td
(2017)Tj
32.5561 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
69 0 obj
<>stream
endstream
endobj
70 0 obj
<>stream
endstream
endobj
71 0 obj
<>stream
endstream
endobj
72 0 obj
<>stream
endstream
endobj
73 0 obj
<>stream
BT
66.402 0 Td
(18)Tj
ET
Q
endstream
endobj
74 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 76 0 R/Contents 77 0 R/TrimBox[0 0 612 792]>>
endobj
76 0 obj
[78 0 R]
endobj
78 0 obj
<>/Border[0 0 0]/A 79 0 R>>
endobj
79 0 obj
<>
endobj
77 0 obj
[80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R]
endobj
80 0 obj
<>stream
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Study)Tj
2.7543 0 Td
(procedures)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(At)Tj
1.2018 0 Td
(baseline,)Tj
3.6567 0 Td
(eligible)Tj
3.0671 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(randomized)Tj
5.057 0 Td
(1:1)Tj
1.4003 0 Td
(to)Tj
1.0261 0 Td
(receive)Tj
3.0047 0 Td
(maraviroc)Tj
4.303 0 Td
(300)Tj
1.6498 0 Td
(mg)Tj
1.5023 0 Td
(qd)Tj
1.2529 0 Td
(\(except)Tj
-32.6095 -1.3039 Td
(those)Tj
2.3357 0 Td
(with)Tj
1.9956 0 Td
(glomerular)Tj
4.6317 0 Td
(filtration)Tj
3.7474 0 Td
(rate,)Tj
1.9729 0 Td
(eGFR,)Tj
/F11 1 Tf
0 Tc
2.7326 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
(80)Tj
1.9446 0 Td
(mL/min)Tj
3.5432 0 Td
(who)Tj
1.9389 0 Td
(received)Tj
3.532 0 Td
(150)Tj
1.6497 0 Td
(mg)Tj
1.5024 0 Td
(qd\))Tj
1.5987 0 Td
(plus)Tj
1.8709 0 Td
(daru-)Tj
-34.9963 -1.2982 Td
(navir/ritonavir)Tj
6.1454 0 Td
(800/100)Tj
3.4016 0 Td
(mg)Tj
1.5023 0 Td
(\(study,)Tj
2.9594 0 Td
(S,)Tj
0.9184 0 Td
(arm\))Tj
2.1883 0 Td
(or)Tj
1.0942 0 Td
(to)Tj
1.0261 0 Td
(continue)Tj
3.7644 0 Td
(the)Tj
1.4684 0 Td
(previous)Tj
3.651 0 Td
(antiretroviral)Tj
5.5105 0 Td
(regimen)Tj
-33.63 -1.2983 Td
(\(continuation,)Tj
5.9583 0 Td
(C,)Tj
1.1112 0 Td
(arm\).)Tj
2.4094 0 Td
(Follow-up)Tj
4.3314 0 Td
(visits)Tj
2.2336 0 Td
(were)Tj
2.1203 0 Td
(scheduled)Tj
4.2066 0 Td
(at)Tj
0.9525 0 Td
(weeks)Tj
2.6078 0 Td
(4,)Tj
0.9241 0 Td
(12)Tj
1.1735 0 Td
(and)Tj
1.7292 0 Td
(every)Tj
2.347 0 Td
(12)Tj
1.1679 0 Td
(weeks)Tj
-33.2728 -1.3039 Td
(thereafter.)Tj
4.3029 0 Td
(Routine)Tj
3.4129 0 Td
(physical)Tj
3.4526 0 Td
(examination)Tj
5.2327 0 Td
(and)Tj
1.7291 0 Td
(laboratory)Tj
4.354 0 Td
(tests,)Tj
2.1884 0 Td
(including)Tj
4.0421 0 Td
(CD4)Tj
2.092 0 Td
(cell)Tj
1.559 0 Td
(counts)Tj
2.8857 0 Td
(and)Tj
-35.2514 -1.2983 Td
(HIV-1)Tj
2.8459 0 Td
(RNA)Tj
2.262 0 Td
(levels,)Tj
2.6022 0 Td
(were)Tj
2.1203 0 Td
(performed)Tj
4.4731 0 Td
(at)Tj
0.9524 0 Td
(baseline)Tj
3.4299 0 Td
(and)Tj
1.7291 0 Td
(at)Tj
0.9525 0 Td
(each)Tj
2.0296 0 Td
(follow-up)Tj
4.0932 0 Td
(visit.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 597.033 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Efficacy)Tj
3.6897 0 Td
(and)Tj
1.8662 0 Td
(safety)Tj
2.863 0 Td
(outcomes)Tj
4.5119 0 Td
(definition)Tj
4.1622 0 Td
(and)Tj
1.8662 0 Td
(handling)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 580.0818 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Treatment)Tj
4.4446 0 Td
(failure)Tj
2.778 0 Td
(was)Tj
1.7008 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(any)Tj
1.6611 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(following:)Tj
4.2009 0 Td
(virological)Tj
4.4107 0 Td
(failure,)Tj
3.0047 0 Td
(discontinuation)Tj
6.548 0 Td
(or)Tj
-35.4725 -1.3039 Td
(change)Tj
3.0387 0 Td
(of)Tj
1.0148 0 Td
(any)Tj
1.6611 0 Td
(current)Tj
3.1804 0 Td
(drug)Tj
2.1146 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0262 0 Td
(any)Tj
1.6554 0 Td
(cause,)Tj
2.6135 0 Td
(withdrawal)Tj
4.6941 0 Td
(of)Tj
1.0148 0 Td
(consent)Tj
3.3336 0 Td
(after)Tj
2.0352 0 Td
(treatment)Tj
4.1329 0 Td
(initiation,)Tj
-33.2161 -1.2982 Td
(loss)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(follow-up,)Tj
4.3143 0 Td
(progression)Tj
4.9209 0 Td
(to)Tj
1.0261 0 Td
(AIDS)Tj
2.4548 0 Td
(or)Tj
1.0999 0 Td
(death.)Tj
2.6588 0 Td
(Virological)Tj
4.6488 0 Td
(failure)Tj
2.778 0 Td
(was)Tj
1.6951 0 Td
(defined)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(second)Tj
-34.0325 -1.2983 Td
(of)Tj
1.0147 0 Td
(two)Tj
1.7065 0 Td
(consecutive)Tj
4.8812 0 Td
(HIV-1)Tj
2.846 0 Td
(RNA)Tj
2.262 0 Td
(levels)Tj
/F11 1 Tf
0 Tc
2.3754 0 Td
(>)Tj
/F6 1 Tf
-0.004 Tc
(50)Tj
1.9446 0 Td
(copies/mL)Tj
4.405 0 Td
(or)Tj
1.0998 0 Td
(a)Tj
0.652 0 Td
(single)Tj
2.5342 0 Td
(HIV-1)Tj
2.8459 0 Td
(RNA)Tj
2.2621 0 Td
(level)Tj
/F11 1 Tf
0 Tc
2.0125 0 Td
(>)Tj
/F6 1 Tf
-0.004 Tc
(1,000)Tj
-32.8419 -1.3039 Td
(copies/mL.)Tj
4.6317 0 Td
(At)Tj
1.2019 0 Td
(the)Tj
1.4684 0 Td
(time)Tj
2.0295 0 Td
(of)Tj
1.0148 0 Td
(virological)Tj
4.4107 0 Td
(failure,)Tj
2.9991 0 Td
(an)Tj
1.2075 0 Td
(additional)Tj
4.2746 0 Td
(visit)Tj
1.8709 0 Td
(and)Tj
1.7291 0 Td
(blood)Tj
2.5115 0 Td
(sampling)Tj
3.8834 0 Td
(were)Tj
-33.2331 -1.2983 Td
(performed.)Tj
4.6941 0 Td
(Clinical)Tj
3.3165 0 Td
(and)Tj
1.7291 0 Td
(laboratory)Tj
4.3484 0 Td
(adverse)Tj
3.2201 0 Td
(events)Tj
2.7269 0 Td
(occurring)Tj
4.1272 0 Td
(during)Tj
2.9254 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3924 0 Td
(were)Tj
2.1203 0 Td
(graded)Tj
-33.0687 -1.2982 Td
(according)Tj
4.1839 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.474 0 Td
(latest)Tj
2.279 0 Td
(available)Tj
3.6681 0 Td
(Division)Tj
3.6283 0 Td
(of)Tj
1.0148 0 Td
(AIDS)Tj
2.4548 0 Td
(tables.)Tj
2.7155 0 Td
(A)Tj
0.9014 0 Td
(Data)Tj
2.126 0 Td
(Safety)Tj
2.5909 0 Td
(Monitoring)Tj
4.8925 0 Td
(Board)Tj
2.6419 0 Td
(was)Tj
-35.5972 -1.304 Td
(established)Tj
4.5977 0 Td
(to)Tj
1.0205 0 Td
(monitor)Tj
3.5433 0 Td
(patient)Tj
3.0047 0 Td
(safety)Tj
2.4774 0 Td
(and)Tj
1.7348 0 Td
(treatment)Tj
4.1329 0 Td
(efficacy)Tj
3.2258 0 Td
(data.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 462.0472 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Study)Tj
2.7543 0 Td
(endpoints)Tj
4.4977 0 Td
(and)Tj
1.8614 0 Td
(sample)Tj
3.4063 0 Td
(size)Tj
1.9796 0 Td
(calculation)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 445.0393 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(primary)Tj
3.4582 0 Td
(study)Tj
2.3868 0 Td
(endpoint)Tj
3.8608 0 Td
(was)Tj
1.6951 0 Td
(the)Tj
1.474 0 Td
(proportion)Tj
4.6318 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
(free)Tj
1.7234 0 Td
(of)Tj
1.0148 0 Td
(treatment)Tj
4.1386 0 Td
(failure)Tj
2.7779 0 Td
(at)Tj
0.9525 0 Td
(48)Tj
-34.2763 -1.2982 Td
(weeks)Tj
2.6078 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(per-protocol)Tj
5.2611 0 Td
(population.)Tj
4.8132 0 Td
(Based)Tj
2.5455 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.474 0 Td
(assumption)Tj
4.8585 0 Td
(that)Tj
1.7802 0 Td
(90%)Tj
1.9275 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3676 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
-34.7071 -1.3039 Td
(continuation)Tj
5.3971 0 Td
(arm)Tj
1.8425 0 Td
(would)Tj
2.7099 0 Td
(meet)Tj
2.1883 0 Td
(the)Tj
1.4684 0 Td
(primary)Tj
3.4582 0 Td
(outcome,)Tj
3.9515 0 Td
(enrolment)Tj
4.405 0 Td
(of)Tj
1.0148 0 Td
(330)Tj
1.6497 0 Td
(patients)Tj
3.3676 0 Td
(distributed)Tj
4.5921 0 Td
(1:1)Tj
-36.0451 -1.2983 Td
(in)Tj
1.0318 0 Td
(each)Tj
2.0295 0 Td
(study)Tj
2.3925 0 Td
(arm)Tj
1.8425 0 Td
(was)Tj
1.7008 0 Td
(planned)Tj
3.4639 0 Td
(in)Tj
1.0374 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0262 0 Td
(test)Tj
1.5987 0 Td
(non-inferiority)Tj
6.2418 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(study)Tj
2.3867 0 Td
(arm)Tj
1.8482 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6519 0 Td
(lower)Tj
-34.1515 -1.2983 Td
(bound)Tj
2.8346 0 Td
(of)Tj
1.0148 0 Td
(10%,)Tj
2.1543 0 Td
(a)Tj
0.6576 0 Td
(confidence)Tj
4.5978 0 Td
(interval)Tj
3.2655 0 Td
(of)Tj
1.0148 0 Td
(95%)Tj
1.9275 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.6577 0 Td
(power)Tj
2.7212 0 Td
(of)Tj
1.0148 0 Td
(80%.)Tj
2.1543 0 Td
(Secondary)Tj
4.3824 0 Td
(endpoints)Tj
4.2236 0 Td
(were:)Tj
-34.35 -1.3039 Td
(the)Tj
1.4683 0 Td
(proportion)Tj
4.6318 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(treatment)Tj
4.1385 0 Td
(failure)Tj
2.778 0 Td
(and)Tj
1.7291 0 Td
(virological)Tj
4.4107 0 Td
(failure)Tj
2.7779 0 Td
(at)Tj
0.9524 0 Td
(48)Tj
1.1679 0 Td
(weeks)Tj
2.6135 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
-34.3216 -1.2982 Td
(intention-to-treat)Tj
7.2566 0 Td
(population,)Tj
4.8189 0 Td
(modification)Tj
5.3744 0 Td
(of)Tj
1.0148 0 Td
(CD4)Tj
2.092 0 Td
(cell)Tj
1.559 0 Td
(count)Tj
2.5285 0 Td
(and)Tj
1.7291 0 Td
(of)Tj
1.0148 0 Td
(blood)Tj
2.5172 0 Td
(metabolic)Tj
4.1442 0 Td
(parame-)Tj
-34.0495 -1.2983 Td
(ters,)Tj
1.8992 0 Td
(changes)Tj
3.4015 0 Td
(in)Tj
1.0375 0 Td
(bone)Tj
2.2053 0 Td
(parameters,)Tj
4.8983 0 Td
(self-reported)Tj
5.3291 0 Td
(adherence)Tj
4.3256 0 Td
(and)Tj
1.7291 0 Td
(symptoms)Tj
4.3597 0 Td
(scores,)Tj
2.8913 0 Td
(and)Tj
1.7291 0 Td
(of)Tj
-33.8057 -1.2983 Td
(health-related)Tj
5.7486 0 Td
(Quality)Tj
3.1974 0 Td
(of)Tj
1.0148 0 Td
(Life)Tj
1.7348 0 Td
(from)Tj
2.2054 0 Td
(baseline)Tj
3.4355 0 Td
(to)Tj
1.0205 0 Td
(week)Tj
2.2507 0 Td
(48.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 314.022 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Evaluation)Tj
4.8283 0 Td
(of)Tj
1.0441 0 Td
(bone)Tj
2.4142 0 Td
(mineral)Tj
3.4536 0 Td
(density)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 297.0141 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(At)Tj
1.2018 0 Td
(baseline)Tj
3.4299 0 Td
(and)Tj
1.7292 0 Td
(at)Tj
0.9524 0 Td
(week)Tj
2.2507 0 Td
(48,)Tj
1.3946 0 Td
(patients)Tj
3.3676 0 Td
(from)Tj
2.2053 0 Td
(7)Tj
0.6973 0 Td
(study)Tj
2.3868 0 Td
(sites)Tj
1.9332 0 Td
(underwent)Tj
4.5751 0 Td
(dual-energy)Tj
4.9889 0 Td
(X-ray)Tj
2.4832 0 Td
(absorpti-)Tj
-33.596 -1.2982 Td
(ometry)Tj
3.0954 0 Td
(scans)Tj
2.347 0 Td
(to)Tj
1.0262 0 Td
(analyze)Tj
3.1691 0 Td
(bone)Tj
2.211 0 Td
(mineral)Tj
3.3278 0 Td
(density)Tj
3.1011 0 Td
(\(BMD\))Tj
3.1068 0 Td
(\(Hologic)Tj
3.7474 0 Td
(Inc.,)Tj
1.9785 0 Td
(Waltham,)Tj
4.1726 0 Td
(MA,)Tj
2.0239 0 Td
(USA\).)Tj
-33.3068 -1.3039 Td
(Total)Tj
2.313 0 Td
(L2L4)Tj
2.7666 0 Td
(lumbar)Tj
3.1238 0 Td
(column)Tj
3.2938 0 Td
(and)Tj
1.7291 0 Td
(femoral)Tj
3.3109 0 Td
(neck)Tj
2.1146 0 Td
(BMD)Tj
2.4264 0 Td
(were)Tj
2.126 0 Td
(recorded.)Tj
4.0195 0 Td
(Moreover,)Tj
4.3937 0 Td
(plasma)Tj
3.033 0 Td
(alka-)Tj
-34.6504 -1.2983 Td
(line)Tj
1.7064 0 Td
(phosphatase)Tj
5.125 0 Td
(\(total)Tj
2.3471 0 Td
(and)Tj
1.7291 0 Td
(bone-associated\),)Tj
7.1603 0 Td
(25\(OH\)vitamin)Tj
6.4516 0 Td
(D,)Tj
1.1849 0 Td
(parathyroid)Tj
4.9265 0 Td
(hormone)Tj
3.9288 0 Td
(\(PTH\))Tj
-34.5597 -1.2983 Td
(and)Tj
1.7291 0 Td
(osteocalcin)Tj
4.6601 0 Td
(were)Tj
2.1203 0 Td
(measured.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 217.9842 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Plasma)Tj
3.5197 0 Td
(drug)Tj
2.1921 0 Td
(levels,)Tj
3.0189 0 Td
(adherence,)Tj
5.1591 0 Td
(patient-reported)Tj
7.1954 0 Td
(symptoms)Tj
4.7386 0 Td
(and)Tj
1.8661 0 Td
(quality)Tj
-27.6899 -1.1669 Td
(of)Tj
1.0441 0 Td
(life)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 186.9732 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Plasma)Tj
3.0727 0 Td
(drug)Tj
2.1089 0 Td
(levels)Tj
2.3755 0 Td
(were)Tj
2.1259 0 Td
(measured)Tj
4.1102 0 Td
(in)Tj
1.0319 0 Td
(arm)Tj
1.8481 0 Td
(S)Tj
0.6917 0 Td
(in)Tj
1.0375 0 Td
(blood)Tj
2.5171 0 Td
(collected)Tj
3.736 0 Td
(before)Tj
2.744 0 Td
(morning)Tj
3.7473 0 Td
(antiretroviral)Tj
-31.1468 -1.2982 Td
(drug)Tj
2.1089 0 Td
(intake)Tj
2.6872 0 Td
(between)Tj
3.532 0 Td
(week)Tj
2.245 0 Td
(4)Tj
0.6973 0 Td
(and)Tj
1.7292 0 Td
(48)Tj
1.1735 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6576 0 Td
(validated)Tj
3.8324 0 Td
(tandem)Tj
3.2712 0 Td
(mass)Tj
2.194 0 Td
(spectrometry)Tj
5.4878 0 Td
(\(UPLC-MS/)Tj
-30.7953 -1.2983 Td
(MS\).)Tj
2.1543 0 Td
(The)Tj
1.7801 0 Td
(time)Tj
2.0296 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(last)Tj
1.5591 0 Td
(drug)Tj
2.1146 0 Td
(intake)Tj
2.6872 0 Td
(and)Tj
1.7292 0 Td
(of)Tj
1.0148 0 Td
(blood)Tj
2.5171 0 Td
(sampling)Tj
3.8778 0 Td
(were)Tj
2.1203 0 Td
(recorded)Tj
3.7984 0 Td
(for)Tj
1.3833 0 Td
(each)Tj
2.0296 0 Td
(patient)Tj
-33.2785 -1.2982 Td
(and)Tj
1.7291 0 Td
(C)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 223.937 146.3244 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(trough)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 246.3307 148.0251 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(were)Tj
2.1203 0 Td
(calculated)Tj
4.2065 0 Td
(accordingly)Tj
4.8869 0 Td
(using)Tj
2.3868 0 Td
(the)Tj
1.474 0 Td
(formula)Tj
3.4129 0 Td
(C)Tj
0.8844 0 Td
(=)Tj
0.7994 0 Td
(C)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 454.6771 146.3244 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(0)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 460.4031 148.0251 cm
BT
/F12 1 Tf
1 TL
-0.004 Tc
0 0 Td
[()]TJ
/F6 1 Tf
0.7936 0 Td
(e)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 472.5354 152.4472 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(-kt)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 483.307 148.0251 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\(C)Tj
1.2245 0 Td
(=)Tj
0.7994 0 Td
(calculated)Tj
4.2066 0 Td
(trough)Tj
-34.5597 -1.3039 Td
(levels;)Tj
2.5965 0 Td
(C)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 232.611 133.3417 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(0)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 238.3937 134.9858 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(=)Tj
0.7993 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.4684 0 Td
(time)Tj
2.0296 0 Td
(measured;)Tj
4.337 0 Td
(K)Tj
0.89 0 Td
(=)Tj
0.7994 0 Td
(elimination)Tj
4.8472 0 Td
(rate)Tj
1.7461 0 Td
(consant)Tj
3.3449 0 Td
(\(0.693/t)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 481.4929 133.3417 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1/2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 491.074 134.9858 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\);)Tj
0.7823 0 Td
(e)Tj
0.6463 0 Td
(=)Tj
0.7994 0 Td
(base)Tj
1.9445 0 Td
(of)Tj
1.0148 0 Td
(natural)Tj
-34.2932 -1.2982 Td
(logaritm\).)Tj
4.1952 0 Td
(Liquid/liquid)Tj
5.5276 0 Td
(extraction)Tj
4.2519 0 Td
(was)Tj
1.7008 0 Td
(employed)Tj
4.1385 0 Td
(for)Tj
1.389 0 Td
(purification)Tj
4.9379 0 Td
(and)Tj
1.7292 0 Td
(concentration)Tj
5.8165 0 Td
(of)Tj
1.0148 0 Td
(mara-)Tj
-34.7014 -1.2983 Td
(viroc,)Tj
2.4661 0 Td
(darunavir)Tj
4.1556 0 Td
(and)Tj
1.7348 0 Td
(ritonavir)Tj
3.736 0 Td
(from)Tj
2.2054 0 Td
(plasma)Tj
3.033 0 Td
(samples.)Tj
3.6113 0 Td
(Samples)Tj
3.4923 0 Td
(were)Tj
2.126 0 Td
(injected)Tj
3.3901 0 Td
(into)Tj
1.8368 0 Td
(an)Tj
1.2019 0 Td
(AQUITY)Tj
-32.9893 -1.3039 Td
(UPLC)Tj
2.7156 0 Td
(system)Tj
2.9366 0 Td
(employing)Tj
4.4731 0 Td
(an)Tj
1.2019 0 Td
(AQUITY)Tj
3.9684 0 Td
(UPLC)Tj
2.7156 0 Td
(BEH)Tj
2.1373 0 Td
(C18)Tj
1.8369 0 Td
(column)Tj
3.2938 0 Td
(\(Waters)Tj
3.4129 0 Td
(Corp.,)Tj
2.7268 0 Td
(Milford,)Tj
3.549 0 Td
(MA,)Tj
-34.9679 -1.2983 Td
(USA\))Tj
2.4548 0 Td
(for)Tj
1.3889 0 Td
(analysis.)Tj
3.549 0 Td
(The)Tj
1.7801 0 Td
(UPLC)Tj
2.7213 0 Td
(was)Tj
1.6951 0 Td
(connected)Tj
4.3483 0 Td
(to)Tj
1.0205 0 Td
(a)Tj
0.6576 0 Td
(triple)Tj
2.3414 0 Td
(quadrupole)Tj
4.8132 0 Td
(tandem)Tj
3.2711 0 Td
(mass)Tj
2.194 0 Td
(detector)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 453.1464 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Switch)Tj
3.1181 0 Td
(to)Tj
1.0417 0 Td
(maraviro)Tj
3.8197 0 Td
(c)Tj
0.7158 0 Td
(with)Tj
1.963 0 Td
(darunavir/r)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01873)Tj
4.089 0 Td
(93)Tj
0 g
2.0906 0 Td
(November)Tj
4.7622 0 Td
(21,)Tj
1.5875 0 Td
(2017)Tj
32.5561 0 Td
(4)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
81 0 obj
<>stream
endstream
endobj
82 0 obj
<>stream
endstream
endobj
83 0 obj
<>stream
endstream
endobj
84 0 obj
<>stream
endstream
endobj
85 0 obj
<>stream
BT
66.402 0 Td
(18)Tj
ET
Q
endstream
endobj
86 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 87 0 R/Contents 88 0 R/TrimBox[0 0 612 792]>>
endobj
87 0 obj
[89 0 R 90 0 R 91 0 R 92 0 R 93 0 R 94 0 R]
endobj
89 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref024)>>
endobj
90 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.ref025)>>
endobj
91 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.g001)>>
endobj
92 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.t001)>>
endobj
93 0 obj
<>/Border[0 0 0]/Dest(Rpone.0187393.s001)>>
endobj
94 0 obj
<>/Border[0 0 0]/A 95 0 R>>
endobj
95 0 obj
<>
endobj
88 0 obj
[96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R 102 0 R 103 0 R 104 0 R]
endobj
96 0 obj
<>stream
q
0.83 0.64 0.02 0 k
384.8882 615.3449 m
394.4126 615.3449 l
h
f*
398.8913 615.3449 m
408.3591 615.3449 l
h
f*
456.0378 120.926 m
475.5969 120.926 l
h
f*
297.411 94.9039 m
326.5512 94.9039 l
h
f*
245.1402 81.9213 m
279.0425 81.9213 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\(Waters)Tj
3.4128 0 Td
(Corp.,)Tj
2.727 0 Td
(Milford,)Tj
3.5489 0 Td
(MA,)Tj
2.0183 0 Td
(USA\))Tj
2.4604 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4684 0 Td
(mass)Tj
2.1996 0 Td
(spectrometric)Tj
5.726 0 Td
(detection.)Tj
4.1612 0 Td
(Data)Tj
2.1203 0 Td
(were)Tj
2.126 0 Td
(processed)Tj
-33.3522 -1.3039 Td
(using)Tj
2.3867 0 Td
(MassLynx)Tj
4.2746 0 Td
(with)Tj
2.0013 0 Td
(a)Tj
0.6519 0 Td
(QuanLynx)Tj
4.4844 0 Td
(program)Tj
3.7077 0 Td
(version)Tj
3.1521 0 Td
(4.1)Tj
1.3947 0 Td
(\(Waters)Tj
3.4128 0 Td
(Corp.,)Tj
2.7326 0 Td
(Milford,)Tj
3.5433 0 Td
(MA,)Tj
2.0239 0 Td
(USA\).)Tj
-33.766 -1.2982 Td
(The)Tj
1.7801 0 Td
(detection)Tj
3.9401 0 Td
(limit)Tj
2.1147 0 Td
(for)Tj
1.3889 0 Td
(the)Tj
1.4684 0 Td
(drug)Tj
2.1146 0 Td
(determination)Tj
5.9527 0 Td
(was)Tj
1.7008 0 Td
(30)Tj
1.1679 0 Td
(ng/mL.)Tj
3.1464 0 Td
(We)Tj
1.6101 0 Td
(computed)Tj
4.2632 0 Td
(C)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 513.1275 679.748 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(trough)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 535.5212 681.3921 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(when)Tj
-33.5506 -1.2982 Td
(maraviroc)Tj
4.2973 0 Td
(levels)Tj
2.3697 0 Td
(were)Tj
2.1203 0 Td
(available)Tj
3.6624 0 Td
(627)Tj
2.1656 0 Td
(hours)Tj
2.5115 0 Td
(after)Tj
2.0296 0 Td
(intake)Tj
2.6872 0 Td
(and)Tj
1.7235 0 Td
(darunavir)Tj
4.1556 0 Td
(1027)Tj
2.6362 0 Td
(hours)Tj
2.5114 0 Td
(after)Tj
2.0295 0 Td
(intake,)Tj
-34.8998 -1.2983 Td
(i.e.)Tj
1.3606 0 Td
(during)Tj
2.9254 0 Td
(the)Tj
1.474 0 Td
(linear)Tj
2.5058 0 Td
(phase)Tj
2.4831 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(elimination)Tj
4.8472 0 Td
(curve.)Tj
2.6419 0 Td
(All)Tj
1.4003 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(instructed)Tj
4.269 0 Td
(to)Tj
1.0261 0 Td
(take)Tj
1.8708 0 Td
(the)Tj
-34.7808 -1.3039 Td
(study)Tj
2.3868 0 Td
(medications)Tj
5.0966 0 Td
(with)Tj
2.0013 0 Td
(food.)Tj
2.2733 0 Td
(In)Tj
1.1112 0 Td
(both)Tj
2.0579 0 Td
(arms,)Tj
2.4322 0 Td
(self-reported)Tj
5.3291 0 Td
(adherence)Tj
4.3199 0 Td
(\(weeks)Tj
2.948 0 Td
(0,)Tj
0.9241 0 Td
(4,)Tj
0.9185 0 Td
(24)Tj
1.1735 0 Td
(and)Tj
1.729 0 Td
(48\),)Tj
-34.7014 -1.2983 Td
(patient-reported)Tj
6.7974 0 Td
(symptoms)Tj
4.3597 0 Td
(and)Tj
1.7291 0 Td
(physical/mental)Tj
6.548 0 Td
(Quality)Tj
3.1975 0 Td
(of)Tj
1.0148 0 Td
(Life)Tj
1.7348 0 Td
(\(QoL\))Tj
2.6928 0 Td
(scores)Tj
2.6703 0 Td
(\(weeks)Tj
2.9479 0 Td
(0)Tj
0.6916 0 Td
(and)Tj
1.7348 0 Td
(48\))Tj
-36.1187 -1.2982 Td
(were)Tj
2.1203 0 Td
(collected)Tj
3.7417 0 Td
(using)Tj
2.3868 0 Td
(validated)Tj
3.8324 0 Td
(questionnaires)Tj
6.0661 0 Td
([)Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7404 0 Td
(25)Tj
0 g
(].)Tj
1.7348 0 Td
(Self-reported)Tj
5.4425 0 Td
(adherence)Tj
4.3257 0 Td
(was)Tj
1.6951 0 Td
(recorded)Tj
-33.0858 -1.3039 Td
(as)Tj
1.0148 0 Td
(indicated)Tj
3.9345 0 Td
(on)Tj
1.2755 0 Td
(a)Tj
0.6577 0 Td
(0100)Tj
2.6362 0 Td
(visual)Tj
2.5115 0 Td
(analogue)Tj
3.8097 0 Td
(scale)Tj
2.1033 0 Td
(\(VAS\).)Tj
2.982 0 Td
(Both)Tj
2.1317 0 Td
(physical)Tj
3.4525 0 Td
(and)Tj
1.7292 0 Td
(mental)Tj
2.9933 0 Td
(health-related)Tj
-31.2319 -1.2983 Td
(QoL)Tj
2.0126 0 Td
(were)Tj
2.1203 0 Td
(assessed)Tj
3.4752 0 Td
(on)Tj
1.2699 0 Td
(a)Tj
0.6577 0 Td
(0100)Tj
2.6362 0 Td
(VAS)Tj
2.0749 0 Td
(scale)Tj
2.109 0 Td
(\(0)Tj
1.0375 0 Td
(=)Tj
0.7993 0 Td
(worst)Tj
2.4435 0 Td
(level;)Tj
2.2393 0 Td
(100)Tj
1.6441 0 Td
(=)Tj
0.7994 0 Td
(best)Tj
1.8142 0 Td
(level\).)Tj
2.5795 0 Td
(In)Tj
1.1055 0 Td
(addition,)Tj
3.8209 0 Td
(the)Tj
-34.639 -1.2983 Td
(questionnaire)Tj
5.7033 0 Td
(included)Tj
3.7133 0 Td
(a)Tj
0.652 0 Td
(list)Tj
1.3946 0 Td
(of)Tj
1.0148 0 Td
(32)Tj
1.1679 0 Td
(common)Tj
3.8494 0 Td
(self-reported)Tj
5.3291 0 Td
(symptoms,)Tj
4.5808 0 Td
(which)Tj
2.6532 0 Td
(were)Tj
2.1203 0 Td
(graded)Tj
-32.1787 -1.3039 Td
(between)Tj
3.5263 0 Td
(0)Tj
0.6973 0 Td
(\(absent\))Tj
3.4696 0 Td
(and)Tj
1.7348 0 Td
(5)Tj
0.6916 0 Td
(\(very)Tj
2.2677 0 Td
(intense\):)Tj
3.6567 0 Td
(mean)Tj
2.4434 0 Td
(values)Tj
2.6646 0 Td
(of)Tj
1.0148 0 Td
(symptoms)Tj
4.3596 0 Td
(were)Tj
2.126 0 Td
(compared)Tj
4.2406 0 Td
(between)Tj
-32.893 -1.2983 Td
(study)Tj
2.3868 0 Td
(arms.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 525.2031 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Statistical)Tj
4.4504 0 Td
(analysis)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 508.1952 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Descriptive)Tj
4.7621 0 Td
(statistics)Tj
3.5887 0 Td
(were)Tj
2.1259 0 Td
(used)Tj
2.058 0 Td
(to)Tj
1.0261 0 Td
(describe)Tj
3.5206 0 Td
(baseline)Tj
3.4356 0 Td
(patients)Tj
3.3675 0 Td
(characteristics,)Tj
6.1285 0 Td
(main)Tj
2.2904 0 Td
(study)Tj
2.3867 0 Td
(out-)Tj
-34.6901 -1.2982 Td
(comes,)Tj
2.9763 0 Td
(laboratory)Tj
4.354 0 Td
(toxicities,)Tj
4.0195 0 Td
(clinical)Tj
3.0784 0 Td
(adverse)Tj
3.2145 0 Td
(events)Tj
2.7326 0 Td
(and)Tj
1.7291 0 Td
(serious)Tj
3.0387 0 Td
(adverse)Tj
3.2145 0 Td
(events.)Tj
2.9536 0 Td
(Differences)Tj
-31.3112 -1.3039 Td
(between)Tj
3.5262 0 Td
(categorical)Tj
4.5128 0 Td
(variables)Tj
3.719 0 Td
(were)Tj
2.126 0 Td
(tested)Tj
2.5511 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(Chi-square)Tj
4.6544 0 Td
(test,)Tj
1.8255 0 Td
(differences)Tj
4.5694 0 Td
(between)Tj
3.5263 0 Td
(continu-)Tj
-33.6583 -1.2983 Td
(ous)Tj
1.6157 0 Td
(variables)Tj
3.719 0 Td
(were)Tj
2.1203 0 Td
(tested)Tj
2.5512 0 Td
(using)Tj
2.3924 0 Td
(the)Tj
1.4683 0 Td
(t-test)Tj
2.2507 0 Td
(or)Tj
1.0999 0 Td
(the)Tj
1.4683 0 Td
(Mann-Whitney)Tj
6.48 0 Td
(U)Tj
0.9581 0 Td
(test,)Tj
1.8255 0 Td
(as)Tj
1.0148 0 Td
(appropriate.)Tj
5.1023 0 Td
(Changes)Tj
-34.0665 -1.2983 Td
(from)Tj
2.2053 0 Td
(baseline)Tj
3.4299 0 Td
(values)Tj
2.6645 0 Td
(at)Tj
0.9525 0 Td
(week)Tj
2.2507 0 Td
(48)Tj
1.1678 0 Td
(were)Tj
2.126 0 Td
(assessed)Tj
3.4696 0 Td
(using)Tj
2.3924 0 Td
(Student's)Tj
3.8948 0 Td
(t-test)Tj
2.2507 0 Td
(for)Tj
1.3833 0 Td
(paired)Tj
2.7609 0 Td
(samples.)Tj
3.6113 0 Td
(The)Tj
-34.5597 -1.2982 Td
(primary)Tj
3.4525 0 Td
(efficacy)Tj
3.2258 0 Td
(endpoint,)Tj
4.0819 0 Td
(treatment)Tj
4.1329 0 Td
(failure,)Tj
3.0047 0 Td
(was)Tj
1.7008 0 Td
(investigated)Tj
4.9889 0 Td
(by)Tj
1.1792 0 Td
(per-protocol)Tj
5.2611 0 Td
(\(PP\))Tj
2.0182 0 Td
(analysis)Tj
3.3279 0 Td
(at)Tj
-36.3739 -1.3039 Td
(study)Tj
2.3867 0 Td
(week)Tj
2.2507 0 Td
(48:)Tj
1.3946 0 Td
(this)Tj
1.6725 0 Td
(analysis)Tj
3.3278 0 Td
(excluded)Tj
3.7871 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(major)Tj
2.6079 0 Td
(protocol)Tj
3.5999 0 Td
(violations.)Tj
4.337 0 Td
(In)Tj
1.1055 0 Td
(addition,)Tj
3.8268 0 Td
(an)Tj
-35.6596 -1.2983 Td
(intention-to-treat)Tj
7.2566 0 Td
(\(ITT\))Tj
2.4661 0 Td
(analysis)Tj
3.3222 0 Td
(at)Tj
0.9524 0 Td
(study)Tj
2.3925 0 Td
(week)Tj
2.245 0 Td
(48)Tj
1.1735 0 Td
(including)Tj
4.0422 0 Td
(all)Tj
1.1452 0 Td
(randomized)Tj
5.057 0 Td
(patients)Tj
3.3732 0 Td
(who)Tj
-33.4259 -1.2983 Td
(received)Tj
3.5319 0 Td
(at)Tj
0.9524 0 Td
(least)Tj
1.9843 0 Td
(one)Tj
1.7007 0 Td
(drug)Tj
2.109 0 Td
(dose)Tj
2.0409 0 Td
(after)Tj
2.0353 0 Td
(randomization)Tj
6.1625 0 Td
(was)Tj
1.7008 0 Td
(also)Tj
1.7688 0 Td
(performed.)Tj
4.6941 0 Td
(In)Tj
1.1055 0 Td
(all)Tj
1.1452 0 Td
(the)Tj
1.474 0 Td
(mentioned)Tj
-32.4054 -1.3039 Td
(analyses)Tj
3.4809 0 Td
(on)Tj
1.2756 0 Td
(treatment)Tj
4.1385 0 Td
(failure,)Tj
2.999 0 Td
(missing)Tj
3.3109 0 Td
(values)Tj
2.6702 0 Td
(and)Tj
1.7291 0 Td
(those)Tj
2.3358 0 Td
(who)Tj
1.9389 0 Td
(had)Tj
1.7121 0 Td
(changed)Tj
3.5659 0 Td
(or)Tj
1.0999 0 Td
(discontinued)Tj
5.4481 0 Td
(their)Tj
-35.7049 -1.2983 Td
(ART)Tj
2.1373 0 Td
(regimen)Tj
3.5376 0 Td
(were)Tj
2.1203 0 Td
(counted)Tj
3.4809 0 Td
(as)Tj
1.0148 0 Td
(failures.)Tj
3.3619 0 Td
(In)Tj
1.1055 0 Td
(a)Tj
0.6576 0 Td
(further)Tj
3.0274 0 Td
(secondary)Tj
4.2689 0 Td
(analysis,)Tj
3.5547 0 Td
(time)Tj
2.0296 0 Td
(to)Tj
1.0261 0 Td
(virological)Tj
4.405 0 Td
(fail-)Tj
-35.7276 -1.2982 Td
(ure)Tj
1.542 0 Td
(was)Tj
1.7008 0 Td
(also)Tj
1.7631 0 Td
(analysed)Tj
3.651 0 Td
(in)Tj
1.0375 0 Td
(all)Tj
1.1452 0 Td
(randomized)Tj
5.0626 0 Td
(patients)Tj
3.3675 0 Td
(divided)Tj
3.2145 0 Td
(by)Tj
1.1792 0 Td
(study)Tj
2.3924 0 Td
(arm,)Tj
2.0693 0 Td
(until)Tj
2.109 0 Td
(last)Tj
1.559 0 Td
(available)Tj
3.668 0 Td
(fol-)Tj
-35.4611 -1.3039 Td
(low-up)Tj
3.05 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.4684 0 Td
(time)Tj
2.0296 0 Td
(of)Tj
1.0148 0 Td
(study)Tj
2.3924 0 Td
(interruption,)Tj
5.3915 0 Td
(using)Tj
2.3867 0 Td
(the)Tj
1.474 0 Td
(Kaplan-Meier)Tj
5.7997 0 Td
(method.)Tj
3.5489 0 Td
(Non-inferiority)Tj
6.429 0 Td
(for)Tj
-35.9374 -1.2983 Td
(the)Tj
1.4683 0 Td
(primary)Tj
3.4582 0 Td
(outcome)Tj
3.7247 0 Td
(was)Tj
1.7008 0 Td
(tested)Tj
2.5512 0 Td
(using)Tj
2.3867 0 Td
(the)Tj
1.4684 0 Td
(one-sided)Tj
4.1612 0 Td
(test)Tj
1.5987 0 Td
(procedure:)Tj
4.5411 0 Td
(noninferiority)Tj
5.8847 0 Td
(would)Tj
2.7156 0 Td
(be)Tj
-35.6596 -1.2983 Td
(established)Tj
4.5977 0 Td
(at)Tj
0.9525 0 Td
(an)Tj
1.2018 0 Td
(alpha)Tj
2.3755 0 Td
(level)Tj
2.0182 0 Td
(of)Tj
1.0148 0 Td
(0.05)Tj
1.8709 0 Td
(if)Tj
0.7766 0 Td
(the)Tj
1.4684 0 Td
(dual)Tj
1.9559 0 Td
(therapy)Tj
3.2485 0 Td
(arm)Tj
1.8425 0 Td
(achieved)Tj
3.702 0 Td
(the)Tj
1.4683 0 Td
(primary)Tj
3.4583 0 Td
(outcome)Tj
3.7247 0 Td
(in)Tj
-35.6766 -1.2982 Td
(no)Tj
1.2755 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(10%)Tj
1.9276 0 Td
(less)Tj
1.61 0 Td
(patients)Tj
3.3676 0 Td
(than)Tj
2.0296 0 Td
(the)Tj
1.4683 0 Td
(current)Tj
3.1861 0 Td
(therapy)Tj
3.2485 0 Td
(arm.)Tj
-21.288 -1.3039 Td
(A)Tj
0.907 0 Td
(two)Tj
1.7065 0 Td
(tailed)Tj
2.4208 0 Td
(P)Tj
0.7766 0 Td
(value)Tj
/F11 1 Tf
0 Tc
2.3074 0 Td
(<)Tj
/F6 1 Tf
-0.004 Tc
(0.05)Tj
2.6419 0 Td
(was)Tj
1.7008 0 Td
(considered)Tj
4.6034 0 Td
(to)Tj
1.0205 0 Td
(be)Tj
1.1508 0 Td
(statistically)Tj
4.6092 0 Td
(significant.)Tj
4.6147 0 Td
(All)Tj
1.4003 0 Td
(analyses)Tj
3.481 0 Td
(were)Tj
-34.5371 -1.2983 Td
(performed)Tj
4.4673 0 Td
(using)Tj
2.3924 0 Td
(the)Tj
1.4684 0 Td
(SPSS)Tj
2.2053 0 Td
(version)Tj
3.1521 0 Td
(22)Tj
1.1736 0 Td
(software)Tj
3.5829 0 Td
(package)Tj
3.4186 0 Td
(\(IBM,)Tj
2.5965 0 Td
(SPSS,)Tj
2.4321 0 Td
(Chicago,)Tj
3.7304 0 Td
(IL,)Tj
1.3266 0 Td
(USA,)Tj
2.3414 0 Td
(IBM\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 261.0141 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Results)Tj
/F0 1 Tf
0 -1.5023 Td
(Patient)Tj
3.2976 0 Td
(characteristics)Tj
6.5386 0 Td
(at)Tj
1.0442 0 Td
(baseline)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 225.9779 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Between)Tj
3.5999 0 Td
(May)Tj
2.0013 0 Td
(23,)Tj
1.3946 0 Td
(2011)Tj
2.126 0 Td
(and)Tj
1.7291 0 Td
(April)Tj
2.3074 0 Td
(22,)Tj
1.3946 0 Td
(2015,)Tj
2.3471 0 Td
(259)Tj
1.6498 0 Td
(patients)Tj
3.3675 0 Td
(underwent)Tj
4.5751 0 Td
(screening)Tj
4.0478 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(study.)Tj
2.6136 0 Td
(On)Tj
-36.0111 -1.2982 Td
(June)Tj
2.0466 0 Td
(2015,)Tj
2.347 0 Td
(based)Tj
2.4775 0 Td
(on)Tj
1.2756 0 Td
(a)Tj
0.6519 0 Td
(pre-planned)Tj
5.1307 0 Td
(48-week)Tj
3.549 0 Td
(interim)Tj
3.2144 0 Td
(analysis,)Tj
3.549 0 Td
(the)Tj
1.474 0 Td
(Data)Tj
2.1203 0 Td
(Safety)Tj
2.5965 0 Td
(Monitoring)Tj
-30.4325 -1.2983 Td
(Board)Tj
2.6362 0 Td
(recommended)Tj
6.0377 0 Td
(trial)Tj
1.8368 0 Td
(discontinuation)Tj
6.5537 0 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0262 0 Td
(an)Tj
1.2018 0 Td
(excess)Tj
2.6816 0 Td
(of)Tj
1.0148 0 Td
(virological)Tj
4.405 0 Td
(failures)Tj
3.1408 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(study)Tj
-34.7355 -1.3039 Td
(arm.)Tj
2.0692 0 Td
(At)Tj
1.2019 0 Td
(that)Tj
1.7802 0 Td
(time,)Tj
2.2507 0 Td
(screening)Tj
4.0535 0 Td
(failures)Tj
3.1407 0 Td
(were)Tj
2.1203 0 Td
(89/259)Tj
2.931 0 Td
(\(36%\):)Tj
2.829 0 Td
(67)Tj
1.1735 0 Td
(\(26%\))Tj
2.6079 0 Td
(for)Tj
1.389 0 Td
(non-R5)Tj
3.2711 0 Td
(viral)Tj
1.9899 0 Td
(tropism,)Tj
3.5887 0 Td
(11)Tj
-36.3966 -1.2983 Td
(\(4%\))Tj
2.1316 0 Td
(for)Tj
1.389 0 Td
(HIV-RNA)Tj
/F11 1 Tf
0 Tc
4.4106 0 Td
(>)Tj
/F6 1 Tf
-0.004 Tc
(50)Tj
1.9446 0 Td
(copies/mL,)Tj
4.6318 0 Td
(6)Tj
0.6973 0 Td
(\(2%\))Tj
2.1316 0 Td
(for)Tj
1.3833 0 Td
(V3)Tj
1.3947 0 Td
(region)Tj
2.8006 0 Td
(of)Tj
1.0148 0 Td
(HIV-1)Tj
2.8459 0 Td
(gp120)Tj
2.6306 0 Td
(not)Tj
1.576 0 Td
(amplifiable,)Tj
4.8926 0 Td
(5)Tj
-35.875 -1.2982 Td
(\(2%\))Tj
2.1316 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(other)Tj
2.3471 0 Td
(exclusion)Tj
3.9855 0 Td
(criteria.)Tj
3.3051 0 Td
(Five)Tj
1.8936 0 Td
(\(2%\))Tj
2.1316 0 Td
(additional)Tj
4.2746 0 Td
(patients)Tj
3.3732 0 Td
(were)Tj
2.1203 0 Td
(excluded)Tj
3.7871 0 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(con-)Tj
-34.7978 -1.2983 Td
(sent)Tj
1.8481 0 Td
(withdrawal)Tj
4.6942 0 Td
(before)Tj
2.7439 0 Td
(randomization.)Tj
6.3892 0 Td
(Therefore,)Tj
4.388 0 Td
(165)Tj
1.6498 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(randomized)Tj
5.0627 0 Td
(of)Tj
1.0148 0 Td
(whom)Tj
2.7552 0 Td
(123)Tj
-36.0337 -1.3039 Td
(were)Tj
2.1203 0 Td
(evaluable)Tj
3.9174 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(48-weeks)Tj
3.9118 0 Td
(ITT)Tj
1.7801 0 Td
(analysis)Tj
3.3279 0 Td
(\(62)Tj
1.508 0 Td
(in)Tj
1.0375 0 Td
(arm)Tj
1.8425 0 Td
(S)Tj
0.6973 0 Td
(and)Tj
1.7291 0 Td
(61)Tj
1.1736 0 Td
(in)Tj
1.0375 0 Td
(arm)Tj
1.8425 0 Td
(C\),)Tj
1.4513 0 Td
(and)Tj
1.7291 0 Td
(115)Tj
1.6441 0 Td
(were)Tj
-33.6073 -1.2983 Td
(included)Tj
3.7133 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4684 0 Td
(main)Tj
2.2903 0 Td
(PP)Tj
1.338 0 Td
(analysis)Tj
3.3278 0 Td
(\(56)Tj
1.5137 0 Td
(in)Tj
1.0318 0 Td
(arm)Tj
1.8482 0 Td
(S)Tj
0.6917 0 Td
(and)Tj
1.7347 0 Td
(59)Tj
1.1679 0 Td
(in)Tj
1.0375 0 Td
(arm)Tj
1.8425 0 Td
(C\))Tj
1.2246 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8198 0 Td
(1)Tj
0 g
(\).)Tj
-25.8858 -1.2982 Td
(The)Tj
1.7858 0 Td
(main)Tj
2.2904 0 Td
(baseline)Tj
3.4299 0 Td
(characteristics)Tj
5.9017 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4741 0 Td
(PP)Tj
1.3379 0 Td
(study)Tj
2.3868 0 Td
(population,)Tj
4.8188 0 Td
(overall)Tj
2.9027 0 Td
(and)Tj
1.7291 0 Td
(divided)Tj
3.2145 0 Td
(by)Tj
1.1792 0 Td
(study)Tj
-34.6618 -1.304 Td
(arm,)Tj
2.0692 0 Td
(are)Tj
1.4514 0 Td
(summarized)Tj
5.1817 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0374 0 Td
(Table)Tj
2.4378 0 Td
(1)Tj
0 g
(,)Tj
0.9241 0 Td
(while)Tj
2.3697 0 Td
(the)Tj
1.4684 0 Td
(respective)Tj
4.1839 0 Td
(details)Tj
2.7779 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(ITT)Tj
1.7802 0 Td
(population)Tj
4.5921 0 Td
(are)Tj
1.4456 0 Td
(sum-)Tj
-34.5767 -1.2982 Td
(marized)Tj
3.4752 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0375 0 Td
(S1)Tj
1.1678 0 Td
(Table)Tj
0 g
(.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 453.1464 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Switch)Tj
3.1181 0 Td
(to)Tj
1.0417 0 Td
(maraviro)Tj
3.8197 0 Td
(c)Tj
0.7158 0 Td
(with)Tj
1.963 0 Td
(darunavir/r)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01873)Tj
4.089 0 Td
(93)Tj
0 g
2.0906 0 Td
(November)Tj
4.7622 0 Td
(21,)Tj
1.5875 0 Td
(2017)Tj
32.5561 0 Td
(5)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
97 0 obj
<>stream
endstream
endobj
98 0 obj
<>stream
endstream
endobj
99 0 obj
<>stream
endstream
endobj
100 0 obj
<>stream
endstream
endobj
101 0 obj
<>stream
endstream
endobj
102 0 obj
<>stream
endstream
endobj
103 0 obj
<>stream
endstream
endobj
104 0 obj
<>stream
BT
66.402 0 Td
(18)Tj
ET
Q
endstream
endobj
105 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 107 0 R/Contents 108 0 R/TrimBox[0 0 612 792]>>
endobj
106 0 obj
<>stream
xwEw$ "JPI AaA%@ tA*D%AEIdɻgOTWݺUuY>[? H@$ H@$ H@$ H@$ H@$ H@$ H@$ H@$ H@$ H@$ H@$ H@$ H@$ H]kJa6aPkAg*fߊe[J=wu]__Ǐ\$ H@$ H@ڄ@ĘL8q~뭷dnNC@xV\qPL7ڥI@$ H@$ c>C z>'I\f5iT[aYYgkJײN3}fM]cZ u-eYɯcv/d9e}YNY}L!G!MQ!-Bo5i5ʰ/ڥpv/TV t]c~!B-+gIMtOQY.a6BfWi|Ԅ>'>Ua2g=ƪ4W
qGO(A0ώ5
裏0S$ H@$ H@LT@_*&].S$ H@$ H`;J2DdF(3DyLF>:m H@$ H@$ #ѣ_# !ʭ\*&mGNI$ H@$ H bbIK@Va$ H@$ H@荀Iod$0D*1&CY$ H@$ H@؛ǤO4$0*&g_ H@$ H@$ ![ H@P1鍌$ H@$ H@Fqp7qD.8$UTLj]$ H@$ H@H!w5RyJ@@@Ť6%H@$ H@$ tkL3>3y[+$>*GgD$ H@$ H@]H.t, /3ό5
Zdx% H@$ H@$2<&ZC@Ť5E$ H@$ H@}"`Ipi, H`>1&ǏO=H@$ H@$ H@$b2@v$W*&}%$ H@$ H@Z@ n8qrCH@[ogƘķB$ H@$ H@@v tn+ H@$ H@$0Rc2RvyJ@CǤcvօH@$ H@$ h*z$0 ]s$ H@$ H@O[:~]$nn;|$ H@$ H@$ 14i}$ @E11{k;$ H@$ H@0Ƥ1[% :bbA'C H@$ H@$ I?E@}% H@$ H@$0D>D`u&
o43A8AA6*&.A$ H@$ Hĉ0 k?Ophp \%pk
+WH_}1[!=T42PzWԾtiܫg5j4Lc}\$ H@$ H@@[CnSLbձe͆7|n/NDiu'%O$NgW* T|Nk| gy&f97 H@$ H@$ !'&M=z4/Vyo7=ϯs9oeW_}?C{;s7k$+~s̯~&{aƎ{?l
c=|7_zz/b6F|wq?O%җ$zAq0;ttIKVs_wuD{F}I?$A:eI6Y$ H@$ H@@lvOI7|Ygqn:}{K/Fğǎ[l30L3xlF%HOk&\p_~.?=.qQ
8`
k駟#lr!χz(+\dE;6e 2DCf/?ϷnZoO%Zygw'\؛K/|8Yr%?SO7n5ս뮻m?.,N>=1O$5.Ww}GగlmQ/<3s=7\veav/'BFM4!Ǵlg;` Lجs=wiE:餓bQ;ԁO<1.RMUz0D*?8aGg?Y˱P_n?R?Օ}x /6q%נ ƥ^hpAg!
l!SiO(?cS_K!AWUtvX H@$ H@$ B NV<"tMn="2,y/_wv|."<